<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis - Lee, AL - 2017 | Cochrane Library</title> <meta content="Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis - Lee, AL - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011699.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis - Lee, AL - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011699.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011699.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis" name="citation_title"/> <meta content="Annemarie L Lee" name="citation_author"/> <meta content="A.Lee3@latrobe.edu.au" name="citation_author_email"/> <meta content="Angela T Burge" name="citation_author"/> <meta content="Department of Rehabilitation, Nutrition and Sport, School of Allied Health, La Trobe University" name="citation_author_institution"/> <meta content="Anne E Holland" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD011699.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/09/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011699.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011699.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011699.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Positive‐Pressure Respiration; *Quality of Life; Bronchiectasis [complications, *therapy]; Cough [therapy]; Disease Progression; Hospitalization [statistics &amp; numerical data]; Randomized Controlled Trials as Topic; Respiratory Therapy [*methods]; Sputum [metabolism]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011699.pub2&amp;doi=10.1002/14651858.CD011699.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="i9CklieH";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011699\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011699\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011699.pub2",title:"Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis",firstPublishedDate:"Sep 27, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011699.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011699.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011699.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011699.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011699.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011699.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011699.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011699.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011699.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011699.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11485 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011699.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0086"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/appendices#CD011699-sec-0091"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/table_n/CD011699StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/table_n/CD011699StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#CD011699-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Annemarie L Lee</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#CD011699-cr-0003">Angela T Burge</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information#CD011699-cr-0004">Anne E Holland</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information/en#CD011699-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 September 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011699.pub2">https://doi.org/10.1002/14651858.CD011699.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011699-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011699-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011699-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011699-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011699-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011699-abs-0001" lang="en"> <section id="CD011699-sec-0001"> <h3 class="title" id="CD011699-sec-0001">Background</h3> <p>People with bronchiectasis experience chronic cough and sputum production and require the prescription of airway clearance techniques (ACTs). A common type of ACT prescribed is positive expiratory pressure (PEP) therapy. A previous review has suggested that ACTs including PEP therapy are beneficial compared to no treatment in people with bronchiectasis. However, the efficacy of PEP therapy in a stable clinical state or during an acute exacerbation compared to other ACTs in bronchiectasis is unknown. </p> </section> <section id="CD011699-sec-0002"> <h3 class="title" id="CD011699-sec-0002">Objectives</h3> <p>The primary aim of this review was to determine the effects of PEP therapy compared with other ACTs on health‐related quality of life (HRQOL), rate of acute exacerbations, and incidence of hospitalisation in individuals with stable or an acute exacerbation of bronchiectasis. </p> <p>Secondary aims included determining the effects of PEP therapy upon physiological outcomes and clinical signs and symptoms compared with other ACTs in individuals with stable or an acute exacerbation of bronchiectasis. </p> </section> <section id="CD011699-sec-0003"> <h3 class="title" id="CD011699-sec-0003">Search methods</h3> <p>We searched the Cochrane Airways Group Specialised Register of Trials, PEDro and clinical trials registries from inception to February 2017 and we handsearched relevant journals. </p> </section> <section id="CD011699-sec-0004"> <h3 class="title" id="CD011699-sec-0004">Selection criteria</h3> <p>Randomised controlled parallel and cross‐over trials that compared PEP therapy versus other ACTs in participants with bronchiectasis. </p> </section> <section id="CD011699-sec-0005"> <h3 class="title" id="CD011699-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures as outlined by Cochrane.</p> </section> <section id="CD011699-sec-0006"> <h3 class="title" id="CD011699-sec-0006">Main results</h3> <p>Nine studies involving 213 participants met the inclusion criteria, of which seven were cross‐over in design. All studies included adults with bronchiectasis, with eight including participants in a stable clinical state and one including participants experiencing an acute exacerbation. Eight studies used oscillatory PEP therapy, using either a Flutter or Acapella device and one study used Minimal PEP therapy. The comparison intervention differed between studies. The methodological quality of studies was poor, with cross‐over studies including suboptimal or no washout period, and a lack of blinding of participants, therapists or personnel for outcome measure assessment in most studies. Clinical heterogeneity between studies limited meta‐analysis. </p> <p>Daily use of oscillatory PEP therapy for four weeks was associated with improved general health according to the Short‐Form 36 questionnaire compared to the active cycle of breathing technique (ACBT). When applied for three sessions over one week, minimal PEP therapy resulted in similar improvement in cough‐related quality of life as autogenic drainage (AD) and L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral (ELTGOL). Oscillatory PEP therapy twice daily for four weeks had similar effects on disease‐specific HRQOL (MD ‐0.09, 95% CI ‐0.37 to 0.19; low‐quality evidence). Data were not available to determine the incidence of hospitalisation or rate of exacerbation in clinically stable participants. </p> <p>Two studies of a single session comparison of oscillatory PEP therapy and gravity‐assisted drainage (GAD) with ACBT had contrasting findings. One study found a similar sputum weight produced with both techniques (SMD 0.54g (‐0.38 to 1.46; 20 participants); the other found greater sputum expectoration with GAD and ACBT (SMD 5.6 g (95% CI 2.91 to 8.29: 36 participants). There was no difference in sputum weight yielded between oscillatory PEP therapy and ACBT with GAD when applied daily for four weeks or during an acute exacerbation. Although a single session of oscillatory PEP therapy was associated with less sputum compared to AD (median difference 3.1 g (95% CI 1.5 to 4.8 g; one study, 31 participants), no difference between oscillatory PEP therapy and seated ACBT was evident. PEP therapy had a similar effect on dynamic and static measures of lung volumes and gas exchange as all other ACTs. A single session of oscillatory PEP therapy (Flutter) generated a similar level of fatigue as ACBT with GAD, but greater fatigue was noted with oscillatory PEP therapy compared to ACBT alone. The degree of breathlessness experienced with PEP therapy did not differ from other techniques. Among studies exploring adverse events, only one study reported nausea with use of oscillatory PEP therapy. </p> </section> <section id="CD011699-sec-0007"> <h3 class="title" id="CD011699-sec-0007">Authors' conclusions</h3> <p>PEP therapy appears to have similar effects on HRQOL, symptoms of breathlessness, sputum expectoration, and lung volumes compared to other ACTs when prescribed within a stable clinical state or during an acute exacerbation. The number of studies and the overall quality of the evidence were both low. In view of the chronic nature of bronchiectasis, additional information is needed to establish the long‐term clinical effects of PEP therapy over other ACTs for outcomes that are important to people with bronchiectasis and on clinical parameters which impact on disease progression and patient morbidity in individuals with stable bronchiectasis. In addition, the role of PEP therapy during an acute exacerbation requires further exploration. This information is necessary to provide further guidance for prescription of PEP therapy for people with bronchiectasis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011699-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011699-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011699-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011699-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011699-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011699-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011699-abs-0003" lang="en"> <h3>PEP therapy in bronchiectasis</h3> <p><b>Review question:</b> We reviewed the evidence to identify the effects of positive expiratory pressure (PEP) therapy compared to other airway clearance techniques (ACTs) in people with bronchiectasis. </p> <p><b>Background:</b> People with bronchiectasis have a chronic cough and frequently produce mucus. ACTs assist in the removal of mucus in people with bronchiectasis, with PEP therapy a technique which is commonly prescribed. A previous review suggested that ACTs may be beneficial compared to no treatment, although the strength of this evidence was low. We wanted to discover what the effects were of PEP therapy compared to other ACTs when used by people with bronchiectasis, and whether it provided advantages over other ACTs. </p> <p><b>Study characteristics:</b> Nine studies were included, with a total of 213 people. The average age of participants ranged from 45 to 74 years. Treatment duration ranged from a single session to up to four weeks of treatment. Eight studies examined people who were stable and one study examined people who were experiencing an exacerbation (flare‐up) of bronchiectasis. PEP therapy was compared to a range of ACTs. </p> <p><b>Key results:</b> Two small studies indicated that PEP therapy is as effective as other ACTs at improving quality of life. The duration of hospitalisation when using PEP therapy or other ACTs during a flare‐up was similar. Both PEP therapy and other techniques appear to have a similar effect on the clearance of mucus from the lungs and on lung function. Similiar levels of breathlessness were experienced with PEP therapy and other ACTs. Other outcomes of interest were the rate of hospitalisation but these have not yet been reported. On the basis of this information, the prescription of PEP therapy for people with bronchiectasis is as suitable as any other type of ACT, with no greater advantage of PEP therapy. </p> <p><b>Quality of the evidence:</b> Because of inadequate reporting of methods and small number of participants, the quality of evidence was low. </p> <p>This Cochrane plain language summary is current to May 2017.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011699-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011699-sec-0086"></div> <h3 class="title" id="CD011699-sec-0087">Implications for practice</h3> <section id="CD011699-sec-0087"> <p>There appears to be similar benefits and effects of PEP therapy (oscillatory and non‐oscillatory) to other ACTs in terms of HRQOL, sputum expectoration, lung function, and impact on symptoms. PEP therapy was not superior to any other ACT in the short and long term. The quality of the evidence however, was low, and therefore, these findings should be interpreted with caution. Additional information is required to establish the clinical value of PEP therapy compared to other ACTs on exacerbation rates and incidence of hospitalisation, both outcomes which influence disease progression in bronchiectasis. The effect of PEP therapy during an acute exacerbation of bronchiectasis requires further clarification. </p> </section> <h3 class="title" id="CD011699-sec-0088">Implications for research</h3> <section id="CD011699-sec-0088"> <p>The longer term effect of PEP therapy compared to other ACTs in people with bronchiectasis has not been established and larger scale studies are required to fully evaluate the effects of this therapy on HRQOL, symptoms, hospitalisation rates, and exacerbation frequency. Future trials should ensure that outcome assessors are blinded to the intervention and, in the case of cross‐over trials, an adequate washout period between interventions is applied. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011699-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011699-sec-0022"></div> <div class="table" id="CD011699-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Positive expiratory pressure (PEP) therapy compared with other airway clearance techniques for bronchiectasis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with bronchiectasis </p> <p><b>Settings:</b> hospital inpatient and outpatient department, home‐based therapy </p> <p><b>Intervention:</b> positive expiratory pressure (PEP) therapy </p> <p><b>Comparison:</b> other airway clearance techniques (ACTs) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Other airway clearance techniques (ACTs)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Positive expiratory pressure (PEP) therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cough‐related quality of life (QOL)</b> <br/> assessed with: Leicester cough questionnaire total score. Higher score indicates better QOL. 19 questions on 7‐point Likert scale<br/> Scale from: 3 to 21<br/> follow‐up: mean 1 week </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) was 0.5 points (95% CI 0.1 to 0.5) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) in the intervention group was 0.1 points lower </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised cross‐over trial of minimal PEP therapy vs Autogenic drainage. Duration of intervention of 1 week per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cough‐related quality of life (QOL)</b> <br/> assessed with: Leicester cough questionnaire total score. Higher score indicates better QOL. 19 questions on 7‐point Likert scale<br/> Scale from: 3 to 21<br/> follow‐up: mean 1 week </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) was 0.9 points (95% CI 0.5 to 2.1) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) in the intervention group was 0.4 points lower </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised cross‐over trial of minimal PEP therapy vs ELTGOL. Duration of intervention of 1 week per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life (HRQOL)</b> disease‐specific HRQOL </p> <p>assessed with: Chronic respiratory disease questionnaire total score</p> <p>Scale from: 0 to 28</p> <p>follow‐up: mean 4 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not provided</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean difference (95% CI) between groups was ‐0.09 points per item (‐0.37 to 0.19) in favour of oscillatory PEP therapy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised cross‐over trial of ACBT vs Oscillatory PEP therapy (Flutter). Duration of intervention of 4 weeks per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of acute exacerbations of bronchiectasis</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of acute exacerbation of bronchiectasis ‐</b> not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of hospitalisation</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not provided</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Small participant numbers </p> <p><sup>2</sup>Insufficient power for quality of life comparison </p> <p><sup>3</sup>Method of randomisation and allocation concealment unclear, lack of blinding of participants and personnel, no washout period applied </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011699-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011699-sec-0023"></div> <section id="CD011699-sec-0024"> <h3 class="title" id="CD011699-sec-0024">Description of the condition</h3> <p>Bronchiectasis is a chronic respiratory condition that is defined by a clinical profile of chronic cough with sputum (mucus) production, dyspnoea (uncomfortable breathlessness) and fatigue (<a href="./references#CD011699-bbs2-0070" title="BarkerAF . Bronchiectasis. New England Journal of Medicine2002;346:1383‐93. ">Barker 2002</a>; <a href="./references#CD011699-bbs2-0114" title="McShaneP , NaureckasET , TinoG , StrekME . Non‐cystic fibrosis bronchiectasis. American Journal of Respiratory and Critical Care Medicine2013;188(6):647‐56. ">McShane 2013</a>). Several aetiologies of bronchiectasis are known; it may develop secondary to a severe respiratory infection or in association with other conditions, including alpha‐1 antitrypsin deficiency, which are characterised by inflammation or impaired mucociliary clearance (mucus transport system), or the cause may be idiopathic (unknown) (<a href="./references#CD011699-bbs2-0122" title="PasteurMC , HelliwellSM , HoughtonSJ , WebbSC , FowerakerJE , CauldenRA , et al. An investigation into causative factors in patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine2000;162:1277‐84. ">Pasteur 2000</a>; <a href="./references#CD011699-bbs2-0091" title="GoeminnePC , ScheersH , DecraeneA , SeysS , DupontLJ . Risk factors for morbidity and death in non‐cystic fibrosis bronchiectasis: a retrospective, cross‐sectional analysis of CT diagnosed bronchiectasis patients. Respiratory Research2012;13:21. ">Goeminne 2012</a>; <a href="./references#CD011699-bbs2-0082" title="CorteseR , MennittiMC , MarianiF , PIloniD , AlibertiS , OtlavianiS , et al. Bronchiectasis in patients with alpha1‐antitrypsin deficiency: prevalence and characteristics. European Respiratory Journal2016;48(Suppl 60):PA737. ">Cortese 2016</a>). Bronchiectasis unrelated to cystic fibrosis (CF) has been previously referred to as non‐CF bronchiectasis, but a recent consensus agreed that this term undermines the severity, morbidity, and prognosis associated with bronchiectasis not originating from CF (<a href="./references#CD011699-bbs2-0067" title="AlibertiS , MasefieldS , PolverinoE , DeSoyzaA , LoebingerMR , MenendezR , et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration. European Respiratory Journal2016;48:632‐47. ">Aliberti 2016</a>); therefore bronchiectasis is now the accepted term to describe this condition. Bronchiectasis originates from a recurring cycle of infection and inflammation, with infection causing chronic inflammation leading to tissue damage and impaired mucociliary clearance (<a href="./references#CD011699-bbs2-0081" title="ColeJ . Inflammation: a two‐edged sword ‐ the model of bronchiectasis. European Review of Respiratory Disease1986;147:6‐15. ">Cole 1986</a>). These pathophysiological (disease) processes increase the risk of further infection, with a cycle of progressive inflammation resulting in structural changes to the airways (<a href="./references#CD011699-bbs2-0081" title="ColeJ . Inflammation: a two‐edged sword ‐ the model of bronchiectasis. European Review of Respiratory Disease1986;147:6‐15. ">Cole 1986</a>; <a href="./references#CD011699-bbs2-0089" title="GagaM , BentleyAM , HumbertM , BarkansJ , O'BrienF , WathenCG , et al. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax1998;53:685‐91. ">Gaga 1998</a>). The pathophysiology is characterised by a history of recurrent acute exacerbations (flare‐ups) (<a href="./references#CD011699-bbs2-0099" title="KingPT , HoldsworthSR , FreezerNJ , VillanuevaE , HolmesPW . Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respiratory Medicine2006;100:2183‐9. ">King 2006</a>), which often require hospitalisation. This condition may affect both children and adults (<a href="./references#CD011699-bbs2-0098" title="KaradagB , KarakocF , ErsuR , KutA , BakacS , DagliE . Non‐cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration2005;72(3):233‐8. ">Karadag 2005</a>; <a href="./references#CD011699-bbs2-0078" title="ChangAB , GrimwoodK , MaguireG , KingPT , MorrisPS , TorzilloPJ . Management of bronchiectasis and chronic suppurative lung disease in Indigenous children and adults from rural and remote Australian communities. Medical Journal of Australia2008;189(7):386‐93. ">Chang 2008</a>; <a href="./references#CD011699-bbs2-0079" title="ChangAB , BellSC , ByrnesCA , GrimwoodK , HolmesPW , KingPT , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. A position statement from the Thoracic Society of Australia and New Zealand and the Australian Lung Foundation. Medical Journal of Australia2010;193(6):356‐65. ">Chang 2010</a>; <a href="./references#CD011699-bbs2-0123" title="PasteurMC , BiltonD , HillAT , on behalf of the British Thoracic Society Bronchiectasis (non‐CF) Guideline Group, a sub‐group of the British Thoracic Society Standards of Care Committee. British Thoracic Society guideline for non‐CF bronchiectasis. Thorax2010;65(Suppl 1):1‐64. ">Pasteur 2010</a>). </p> <p>The global prevalence is not accurately known but estimates from earlier studies have ranged from 0.5 cases per 100,000 in Finland (<a href="./references#CD011699-bbs2-0133" title="SäynäjäkangasO , KeistinenT , TuuponenT , KiveläSL . Bronchiectasis in Finland: trends in hospital treatment. Respiratory Medicine1997;91(7):395‐8. ">Säynäjäkangas 1997</a>) to 1106 cases per 100,000 population over an eight‐year period in the United States of America (USA) (<a href="./references#CD011699-bbs2-0132" title="SeitzAE , OlivierKN , AdjemianJ , HollandSM , PrevotsR . Trends in bronchiectasis amongst Medicare beneficiaries in the United States, 2000 to 2007. Chest2012;142(2):432‐9. ">Seitz 2012</a>). More recently, higher prevalence rates were reported in the UK in 2013, with 566.1 per 100,000 in females and 485.5 per 100,000 in males (<a href="./references#CD011699-bbs2-0125" title="QuintJK , MillettER , JoshiM , NavaratnamV , ThomasSL , HurstJR , et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population‐based cohort study. European Respiratory Journal2016;47(1):186‐93. ">Quint 2016</a>), while the prevalence was 3.6 cases per 1000 in 2012 in Catalonia (<a href="./references#CD011699-bbs2-0115" title="MonteagudoM , Rodriguez‐BlancoT , BarrechegurenM , SimonetP , MiravitllesM . Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population‐based study. Respiratory Medicine2016;121:26‐31. ">Monteagudo 2016</a>). In New Zealand, the reported prevalence is 3.7 per 100,000 population, but this varies according to ethnicity (<a href="./references#CD011699-bbs2-0134" title='TwissJ , MetcalfeR , EdwardsE , ByrnesC . New Zealand national incidence of bronchiectasis "too high" for a developed country. Archives of Diseases of Childhood2005;90(7):737‐40. '>Twiss 2005</a>), and in Australia, the prevalence amongst indigenous children is 1470 per 100,000 (<a href="./references#CD011699-bbs2-0077" title="ChangAB , GrimwoodK , MulhollandEK , TorzilloPJ . Bronchiectasis in Indigenous children in remote Australian communities. Medical Journal of Australia2002;177:200‐4. ">Chang 2002</a>). With increased use of high‐resolution computed tomography (HRCT), bronchiectasis is more frequently identified (<a href="./references#CD011699-bbs2-0139" title="WeyckerD , EdelsbergJ , OsterG , TinoG . Prevalence and economic burden of bronchiectasis. Clinics in Pulmonary Medicine2005;12:205‐9. ">Weycker 2005</a>; <a href="./references#CD011699-bbs2-0101" title="KwakHJ , MoonJY , ChoiYW , KimTH , SohnJW , YoonHJ , et al. High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program. Tohoku Journal of Experimental Medicine2010;222(4):237‐42. ">Kwak 2010</a>), and hospitalisation rates associated with bronchiectasis are on the rise, particularly in older individuals (<a href="./references#CD011699-bbs2-0131" title="SeitzA , OlivierKN , SteinerCA , Montes de OcaR , HollandSM , PrevotsDR . Trends and burden of bronchiectasis‐associated hospitalisations in the United States 1993 ‐ 2006. Chest2010;138(4):944‐9. ">Seitz 2010</a>; <a href="./references#CD011699-bbs2-0132" title="SeitzAE , OlivierKN , AdjemianJ , HollandSM , PrevotsR . Trends in bronchiectasis amongst Medicare beneficiaries in the United States, 2000 to 2007. Chest2012;142(2):432‐9. ">Seitz 2012</a>; <a href="./references#CD011699-bbs2-0128" title="RingshausenFC , DeRouxA , PletzMW , HamalainenN , WelteT , RademacherJ . Bronchiectasis‐associated hospitalisations in Germany, 2005‐2011: a population‐based study of disease burden and trends. PLOS One2013;8(8):E71109. ">Ringshausen 2013</a>). The frequency of these respiratory infections is linked to rising morbidity and mortality (<a href="./references#CD011699-bbs2-0139" title="WeyckerD , EdelsbergJ , OsterG , TinoG . Prevalence and economic burden of bronchiectasis. Clinics in Pulmonary Medicine2005;12:205‐9. ">Weycker 2005</a>; <a href="./references#CD011699-bbs2-0107" title="Martinez‐GarciaMA , Soler‐CatalunaJ‐J , Perpina‐TorderaM , Roman‐SanchezP , SorianoJ . Factors associated with lung function decline in adult patients with stable non‐cystic fibrosis bronchiectasis. Chest2007;32(5):1565‐72. ">Martinez‐Garcia 2007</a>; <a href="./references#CD011699-bbs2-0129" title="RobertsJH , HubbardR . Trends in bronchiectasis in England and Wales. Respiratory Medicine2010;104(7):981‐5. ">Roberts 2010</a>; <a href="./references#CD011699-bbs2-0091" title="GoeminnePC , ScheersH , DecraeneA , SeysS , DupontLJ . Risk factors for morbidity and death in non‐cystic fibrosis bronchiectasis: a retrospective, cross‐sectional analysis of CT diagnosed bronchiectasis patients. Respiratory Research2012;13:21. ">Goeminne 2012</a>; <a href="./references#CD011699-bbs2-0076" title="ChalmersJ , GoeminneP , AlibertiS , McDonnellMJ , LonniS , DavidsonJ , et al. The bronchiectasis severity index. An international derivation and validation study. American Journal of Respiratory and Critical Care Medicine2014;189(5):576–85. ">Chalmers 2014</a>; <a href="./references#CD011699-bbs2-0092" title="GoeminnePC , NawrotTS , RuttensD , SeysS , DupontLJ . Mortality in non‐cystic fibrosis bronchiectasis: a prospective cohort analysis. Respiratory Medicine2014;108(2):287‐96. ">Goeminne 2014</a>) and is a key predictor of reduced health‐related quality of life (HRQOL) in those with bronchiectasis (<a href="./references#CD011699-bbs2-0106" title="Martinez‐GarciaMA , Perpiñá‐TorderaM , Román‐SánchezP , Soler‐CataluñaJJ . Quality‐of‐life determinants in patients with clinically stable bronchiectasis. Chest2005;128(2):739‐45. ">Martinez‐Garcia 2005</a>). </p> </section> <section id="CD011699-sec-0025"> <h3 class="title" id="CD011699-sec-0025">Description of the intervention</h3> <p>Current international guidelines for the management of bronchiectasis focus on minimising further damage to the airways by reducing inflammation and infection and optimising airway clearance (<a href="./references#CD011699-bbs2-0078" title="ChangAB , GrimwoodK , MaguireG , KingPT , MorrisPS , TorzilloPJ . Management of bronchiectasis and chronic suppurative lung disease in Indigenous children and adults from rural and remote Australian communities. Medical Journal of Australia2008;189(7):386‐93. ">Chang 2008</a>; <a href="./references#CD011699-bbs2-0079" title="ChangAB , BellSC , ByrnesCA , GrimwoodK , HolmesPW , KingPT , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. A position statement from the Thoracic Society of Australia and New Zealand and the Australian Lung Foundation. Medical Journal of Australia2010;193(6):356‐65. ">Chang 2010</a>; <a href="./references#CD011699-bbs2-0123" title="PasteurMC , BiltonD , HillAT , on behalf of the British Thoracic Society Bronchiectasis (non‐CF) Guideline Group, a sub‐group of the British Thoracic Society Standards of Care Committee. British Thoracic Society guideline for non‐CF bronchiectasis. Thorax2010;65(Suppl 1):1‐64. ">Pasteur 2010</a>; <a href="./references#CD011699-bbs2-0080" title="ChangAB , BellSC , TorzilloPJ , KingPT , MaguireGP , ByrnesCA , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Medical Journal of Australia2015;202(1):21‐3. ">Chang 2015</a>). To achieve this, recommended approaches incorporate the prescription of antibiotics, anti‐inflammatory therapy and mucolytics (mucus loosening agents), together with airway clearance techniques to facilitate sputum clearance (<a href="./references#CD011699-bbs2-0078" title="ChangAB , GrimwoodK , MaguireG , KingPT , MorrisPS , TorzilloPJ . Management of bronchiectasis and chronic suppurative lung disease in Indigenous children and adults from rural and remote Australian communities. Medical Journal of Australia2008;189(7):386‐93. ">Chang 2008</a>; <a href="./references#CD011699-bbs2-0079" title="ChangAB , BellSC , ByrnesCA , GrimwoodK , HolmesPW , KingPT , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. A position statement from the Thoracic Society of Australia and New Zealand and the Australian Lung Foundation. Medical Journal of Australia2010;193(6):356‐65. ">Chang 2010</a>; <a href="./references#CD011699-bbs2-0123" title="PasteurMC , BiltonD , HillAT , on behalf of the British Thoracic Society Bronchiectasis (non‐CF) Guideline Group, a sub‐group of the British Thoracic Society Standards of Care Committee. British Thoracic Society guideline for non‐CF bronchiectasis. Thorax2010;65(Suppl 1):1‐64. ">Pasteur 2010</a>; <a href="./references#CD011699-bbs2-0080" title="ChangAB , BellSC , TorzilloPJ , KingPT , MaguireGP , ByrnesCA , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Medical Journal of Australia2015;202(1):21‐3. ">Chang 2015</a>). A regular programme of airway clearance therapy has been associated with reduced symptoms of coughing and improved HRQOL (<a href="./references#CD011699-bbs2-0116" title="MutalithasK , WatkinG , WilligB , WardlawA , PavordID , BirringSS . Improvement in health status following bronchopulmonary hygiene physical therapy in patients with bronchiectasis. Respiratory Medicine2008;102(8):1140‐4. ">Mutalithas 2008</a>). A recent updated review found that compared with no treatment, performing airway clearance techniques (ACTs) was associated with improvement in sputum expectoration (production), lung function and HRQOL (<a href="./references#CD011699-bbs2-0104" title="LeeAL , BurgeAT , HollandAE . Airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD008351.pub3] ">Lee 2013</a>). When undertaken by individuals with stable bronchiectasis, oscillatory PEP therapy (with repetitive vibrations) was associated with greater sputum expectoration and improved disease‐specific HRQOL and cough‐related QOL compared to no treatment (<a href="./references#CD011699-bbs2-0105" title="LeeAL , WilliamsonHC , LorensiniS , SpencerLM . The effects of oscillating positive expiratory pressure therapy in adults with stable non‐cystic fibrosis bronchiectasis: a systematic review. Chronic Respiratory Disease2015;12(1):36‐46. ">Lee 2015</a>). Less pulmonary hyperinflation (overinflated) was evident with selected ACTs, including oscillatory PEP therapy (<a href="./references#CD011699-bbs2-0104" title="LeeAL , BurgeAT , HollandAE . Airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD008351.pub3] ">Lee 2013</a>). However, when compared to other ACTs, oscillatory PEP therapy in people with stable bronchiectasis led to equivalent changes in sputum volume, dynamic lung volumes and degree of breathlessness (<a href="./references#CD011699-bbs2-0105" title="LeeAL , WilliamsonHC , LorensiniS , SpencerLM . The effects of oscillating positive expiratory pressure therapy in adults with stable non‐cystic fibrosis bronchiectasis: a systematic review. Chronic Respiratory Disease2015;12(1):36‐46. ">Lee 2015</a>). Multiple types of ACTs may be applied in individuals with bronchiectasis. Selected techniques have included forms of breathing exercises, forced expirations or controlled coughing, gravity‐assisted drainage (GAD) and manual techniques, which often are used in combination and may or may not require the assistance of the therapist for maximal efficacy. Other ACT options for promoting sputum clearance include the application of positive expiratory pressure (PEP) therapy through the use of hand‐held devices, which generally do not require the hands‐on assistance of a therapist and therefore may facilitate independent treatment. </p> </section> <section id="CD011699-sec-0026"> <h3 class="title" id="CD011699-sec-0026">How the intervention might work</h3> <p>The theoretical rationale behind the physiological effects of PEP therapy is that in the presence of small airway obstruction caused by secretion retention, the reduced diameter of the airway lumen (internal space) increases expiratory (exhalation) resistance and encourages airway collapse, which may lead to reduced expiratory flow, insufficient expiration and dynamic hyperinflation (<a href="./references#CD011699-bbs2-0121" title="OlsenMF , LanneforsL , WesterdahlE . Positive expiratory pressure: common clinical applications and physiological effects. Respiratory Medicine2015;109(3):297‐307. ">Olsen 2015</a>). PEP therapy has been hypothesised to promote airflow through collateral channels during inspiration to improve ventilation distribution, which allows accumulation of an increased volume of air behind secretions. The pressure gradient across the sputum plug is believed to force secretions centrally towards the larger airways, where expectoration may occur (<a href="./references#CD011699-bbs2-0088" title="FalkM , KelstrupM , AndersenJ , KinoshitaT , FalkP , StøvringS , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. European Journal of Respiratory Disease1984;65:423‐32. ">Falk 1984</a>; <a href="./references#CD011699-bbs2-0135" title="Van derSchansC , Van derMarkT , DeVriesG , PiersDA , BeekhuisH , Dankert‐RoelseJE , et al. Effect of positive expiratory pressure breathing in patients with cystic fibrosis. Thorax1991;46:252‐6. ">Van der Schans 1991</a>). During expiration, the positive pressure generated is thought to encourage airway splinting to stabilise peripheral airways and prevent premature airway collapse during expiration (<a href="./references#CD011699-bbs2-0119" title="OberwaldnerB , EvansJ , ZachM . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatric Pulmonology1986;2:358‐67. ">Oberwaldner 1986</a>; <a href="./references#CD011699-bbs2-0083" title="DarbeeJ , OhtakeP , GrantB , CernyFJ . Physiological evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. Physical Therapy2004;84:524‐37. ">Darbee 2004</a>). Despite these theoretical principles, a study of PEP therapy in participants with chronic obstructive pulmonary disease did not show differences in ventilation distribution (<a href="./references#CD011699-bbs2-0040" title="OsadnikC , Stuart‐AndrewC , EllisS , ThompsonB , McDonaldCF , HollandAE . Positive expiratory pressure via mask does not improve ventilation inhomogeneity more than huffing or coughing in individuals with stable chronic obstructive pulmonary disease and chronic sputum expectoration. Respiration2014;87:38‐44. ">Osadnik 2014</a>), which suggests that the precise mechanism behind PEP therapy is not understood. PEP therapy is applied by inspiring and expiring through a facemask or mouthpiece for a series of breaths via a one‐way valve, followed by forced expiratory manoeuvres (huffing) or a slow expiratory manoeuvre in order to expectorate secretions. PEP therapy may apply low pressure (10 to 25 cmH<sub>2</sub>O) (<a href="./references#CD011699-bbs2-0088" title="FalkM , KelstrupM , AndersenJ , KinoshitaT , FalkP , StøvringS , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. European Journal of Respiratory Disease1984;65:423‐32. ">Falk 1984</a>; <a href="./references#CD011699-bbs2-0094" title="GrothS , StafangerG , DirksenH , AndersenJB , FalkM , KelstrupM . Positive expiratory pressure (PEP‐mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bulletin European de Physiopathologie Respiratoire1985;21(4):339‐43. ">Groth 1985</a>) or high pressure (Hi‐PEP) at 40 to 120 cmH<sub>2</sub>O (<a href="./references#CD011699-bbs2-0119" title="OberwaldnerB , EvansJ , ZachM . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatric Pulmonology1986;2:358‐67. ">Oberwaldner 1986</a>). In contrast to low‐pressure PEP therapy, during Hi‐PEP, forced expiratory manoeuvres are also performed through the facemask to prevent dynamic airway collapse during expiration and to facilitate more peripheral secretion clearance (<a href="./references#CD011699-bbs2-0119" title="OberwaldnerB , EvansJ , ZachM . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatric Pulmonology1986;2:358‐67. ">Oberwaldner 1986</a>; <a href="./references#CD011699-bbs2-0120" title="OberwaldnerB , TheisslB , RuckerA , ZachMS . Chest physiotherapy in hospitalised patients with cystic fibrosis: a study of lung function effects and sputum production. European Respiratory Journal1991;4:152‐8. ">Oberwaldner 1991</a>). Forced expiration against a resistive load is thought to direct air from hyperinflated lung units to unobstructed and atelectatic (collapsed) lung units to encourage a homogenised slow expiratory flow. </p> <p>In comparison, oscillatory PEP therapy offers the combination of PEP and high‐frequency oscillations within the airways during exhalation to facilitate secretion clearance. The PEP component is thought to encourage airflow behind secretions, and the oscillation induces vibrations within the airway wall to displace secretions into the airway lumen; repeated accelerations of expiratory airflow favour movement of secretions from the peripheral to the central airways (<a href="./references#CD011699-bbs2-0069" title="AppE , KieselmannR , ReinhardtD , LindemannH , DasguptaB , KingM , et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Flutter vs autogenic drainage. Chest1998;114:171‐7. ">App 1998</a>; <a href="./references#CD011699-bbs2-0054" title="TambascioJ , DeSouzaLT , LisboaRM , PassarelliRDCV , SouzaHCDD , GastaldiAC . The influence of flutter®VRP1 components on respiratory secretion transport of patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine2011;183:A6410. TambascioJ , DeSouzaLT , LisboaRMh , PassarelliRDCV , DeSouzaHCD , GastaldiAC . The influence of Flutter VRP1 components of mucus transport of patients with bronchiectasis. Respiratory Medicine2011;105:1316‐21. ">Tambascio 2011</a>). Sputum rheology (mucus flow) may also be altered, with oscillations reducing the viscoelasticity (thickness) of the secretions (<a href="./references#CD011699-bbs2-0068" title="AltausP . Oscillating PEP. In: International Physiotherapy Group for Cystic Fibrosis, editor(s). Physiotherapy for people with cystic fibrosis: from infant to adults. 4th Edition. Karup: European Cystic Fibrosis Society, 2009:18‐22. ">Altaus 2009</a>). Several oral devices such as a Flutter valve or Acapella may be used to provide oscillatory PEP therapy. </p> <p>Comparisons of PEP therapy versus oscillatory PEP therapy have been undertaken in both children and adults with cystic fibrosis (<a href="./references#CD011699-bbs2-0136" title="VanWindenCMQ , VisserA , HopW , SterkPJ , BeckersS , DeJongsteJC . Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. European Respiratory Journal1998;12:143‐7. ">Van Winden 1998</a>; <a href="./references#CD011699-bbs2-0112" title="McIlwainePM , WongL , PeacockD , DavidsonAGF . Long‐term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. Journal of Pediatrics2001;138(6):845‐50. ">McIlwaine 2001</a>; <a href="./references#CD011699-bbs2-0117" title="NewboldM , TullisE , CoreyM , RossB , BrooksD . The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiotherapy Canada2008;57(3):199‐207. ">Newbold 2008</a>). Although oscillatory PEP therapy was associated with a greater decline in lung function and an increased rate of hospitalisation compared with PEP therapy over the longer term in children (<a href="./references#CD011699-bbs2-0112" title="McIlwainePM , WongL , PeacockD , DavidsonAGF . Long‐term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. Journal of Pediatrics2001;138(6):845‐50. ">McIlwaine 2001</a>), other studies have reported no difference in effects on lung function between the two types of therapy (<a href="./references#CD011699-bbs2-0136" title="VanWindenCMQ , VisserA , HopW , SterkPJ , BeckersS , DeJongsteJC . Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. European Respiratory Journal1998;12:143‐7. ">Van Winden 1998</a>; <a href="./references#CD011699-bbs2-0117" title="NewboldM , TullisE , CoreyM , RossB , BrooksD . The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiotherapy Canada2008;57(3):199‐207. ">Newbold 2008</a>). In individuals with bronchiectasis, oscillatory PEP therapy was associated with a greater increase in secretion transport compared with PEP therapy (<a href="./references#CD011699-bbs2-0054" title="TambascioJ , DeSouzaLT , LisboaRM , PassarelliRDCV , SouzaHCDD , GastaldiAC . The influence of flutter®VRP1 components on respiratory secretion transport of patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine2011;183:A6410. TambascioJ , DeSouzaLT , LisboaRMh , PassarelliRDCV , DeSouzaHCD , GastaldiAC . The influence of Flutter VRP1 components of mucus transport of patients with bronchiectasis. Respiratory Medicine2011;105:1316‐21. ">Tambascio 2011</a>). This mix of results suggests that the various modes of PEP therapy may have differing clinical and physiological effects. For this reason, it may be important to evaluate the distinct effects of each type of PEP therapy. </p> </section> <section id="CD011699-sec-0027"> <h3 class="title" id="CD011699-sec-0027">Why it is important to do this review</h3> <p>Surveys of clinical practice have illustrated considerable variation in the prescription of ACTs, including use of PEP therapy for both adults and children with bronchiectasis, both in a stable clinical state and during an acute exacerbation (<a href="./references#CD011699-bbs2-0118" title="O'NeillB , BradleyJM , McArdleN , MacMahonJ . The current physiotherapy management of patients with bronchiectasis: a UK survey. International Journal of Clinical Practice2002;56(1):34‐5. ">O'Neill 2002</a>; <a href="./references#CD011699-bbs2-0073" title="ButlerS , HillLJ , HarrisonJ , ReedP , NikoraG , TakaiG , et al. Is there a difference in airway clearance practices between children with non cystic fibrosis bronchiectasis and cystic fibrosis?. New Zealand Journal of Physiotherapy2008;36:112‐7. ">Butler 2008</a>; <a href="./references#CD011699-bbs2-0103" title="LeeAL , ButtonBM , DenehyL . Current physiotherapy practice in Australia and New Zealand for patients with chronic obstructive pulmonary disease and bronchiectasis. New Zealand Journal of Physiotherapy2008;32:49‐58. ">Lee 2008</a>; <a href="./references#CD011699-bbs2-0097" title="JohnstoneCL , JamesR , MackneyJH . The current use of positive expiratory pressure (PEP) therapy by public hospital physiotherapists in New South Wales. New Zealand Journal of Physiotherapy2013;41(3):88‐93. ">Johnstone 2013</a>). Selection of ACTs in this population may be influenced by underlying airway pathophysiology, participant compliance and perception of efficacy, as well as by participant resources (<a href="./references#CD011699-bbs2-0102" title="LapinC . Mixing and matching airway clearance techniques to patients. Pediatric Pulmonology2000;Suppl 21:144‐6. ">Lapin 2002</a>). Of the five studies included in the previous review (<a href="./references#CD011699-bbs2-0104" title="LeeAL , BurgeAT , HollandAE . Airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD008351.pub3] ">Lee 2013</a>), although four applied oscillatory PEP therapy, only a small number of participants (ranging from eight to 20) were included, and the effects were compared with a control condition only. Although the independence of PEP therapy options compared with other treatment options may appeal to both patients and clinicians, the effects of each mode of PEP therapy must be clarified in terms of both physiological and clinical impact when compared with other types of ACTs in individuals with bronchiectasis, to further guide clinical practice. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011699-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011699-sec-0028"></div> <p>The primary aim of this review was to determine the effects of any type of PEP therapy compared with other ACTs on HRQOL, rate of acute exacerbations, and incidence of hospitalisation in individuals with stable or an acute exacerbation of bronchiectasis. </p> <p>Secondary aims included determining the effects of PEP therapy upon physiological outcomes and clinical signs and symptoms compared with other ACTs in individuals with stable or an acute exacerbation of bronchiectasis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011699-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011699-sec-0029"></div> <section id="CD011699-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011699-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) of both parallel and cross‐over design, in which a prescribed mode of PEP therapy was compared with other ACTs in individuals with stable or an acute exacerbation of bronchiectasis. </p> </section> <section id="CD011699-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included studies of both adults and children with a diagnosis of bronchiectasis of any origin, with the exception of CF. The diagnosis of bronchiectasis was based on a physician diagnosis or on HRCT with any degree of disease severity. We included studies of participants in a stable clinical state and experiencing an acute exacerbation. We classified participants as experiencing an acute exacerbation if they met the investigators' definition, or if they had worsening symptoms (increased sputum production, clinical signs of infection or dyspnoea) requiring medical treatment, including antibiotic therapy, and required or didn't require hospitalisation. We classified participants as stable if they met the investigators' definition, or if no change were made to medical therapy and stable symptoms persisted over the previous four weeks. We analysed separately studies of participants diagnosed with an acute exacerbation of bronchiectasis and studies of participants in a stable clinical state, as the prescription for treatment and physiological and clinical effects may differ. </p> <p>We excluded participants diagnosed (on the basis of physician reporting) with concurrent asthma, chronic obstructive pulmonary disease or interstitial lung disease, and those breathing through an artificial airway. Studies of children included participants up to the age of 18 years, and studies of adults included participants older than 18 years. We included studies that incorporated a mix of diagnostic groups only if data on any of the review outcomes could be obtained separately for participants with bronchiectasis. </p> </section> <section id="CD011699-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing PEP therapy with other ACTs (which may include a combination of techniques), with PEP therapy applied as a single technique or in conjunction with other recognised ACTs (e.g. oscillatory PEP therapy with active cycle of breathing technique vs active cycle of breathing technique alone). Types of PEP therapy included any of the following options, which were applied for the primary purpose of sputum removal. </p> <p> <ul id="CD011699-list-0001"> <li> <p>PEP therapy, with pressures ranging from 10 to 25 cmH<sub>2</sub>O (<a href="./references#CD011699-bbs2-0088" title="FalkM , KelstrupM , AndersenJ , KinoshitaT , FalkP , StøvringS , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. European Journal of Respiratory Disease1984;65:423‐32. ">Falk 1984</a>; <a href="./references#CD011699-bbs2-0094" title="GrothS , StafangerG , DirksenH , AndersenJB , FalkM , KelstrupM . Positive expiratory pressure (PEP‐mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bulletin European de Physiopathologie Respiratoire1985;21(4):339‐43. ">Groth 1985</a>), delivered via mask or mouthpiece (including Bottle PEP) (<a href="./references#CD011699-bbs2-0075" title="CampbellT , FergusonN , McKinlayR . The use of a simple self‐administered method of positive expiratory pressure (PEP) in chest physiotherapy after abdominal surgery. Physiotherapy1986;72:498‐500. ">Campbell 1986</a>). </p> </li> <li> <p>Hi‐PEP therapy, with pressures ranging from 40 to 120 cmH<sub>2</sub>O (<a href="./references#CD011699-bbs2-0119" title="OberwaldnerB , EvansJ , ZachM . Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatric Pulmonology1986;2:358‐67. ">Oberwaldner 1986</a>), delivered via mask. </p> </li> <li> <p>Oscillatory PEP therapy, delivered by a device (e.g. Flutter, Acapella, RC‐Cornet, Quaker or Lung Flute) (<a href="./references#CD011699-bbs2-0069" title="AppE , KieselmannR , ReinhardtD , LindemannH , DasguptaB , KingM , et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Flutter vs autogenic drainage. Chest1998;114:171‐7. ">App 1998</a>; <a href="./references#CD011699-bbs2-0068" title="AltausP . Oscillating PEP. In: International Physiotherapy Group for Cystic Fibrosis, editor(s). Physiotherapy for people with cystic fibrosis: from infant to adults. 4th Edition. Karup: European Cystic Fibrosis Society, 2009:18‐22. ">Altaus 2009</a>; <a href="./references#CD011699-bbs2-0048" title="Shabari , PV , AlaparthiGK , Vaishali , V . Comparions of Acapella and RC‐Cornet for airway clearance in bronchiectasis ‐ a pilot study. International Journal of Current Research and Review2011;3(11):138‐48. ">Shabari 2011</a>). </p> </li> <li> <p>Minimal PEP therapy with pressure less than 5 cmH<sub>2</sub>O, delivered via mask or mouthpiece (<a href="./references#CD011699-bbs2-0057" title="NCT00700388 . Efficacy of temporary positive expiratory pressure (TPEP) in chronic hypersecretion (UNIKO) [Multicentre controlled trial on efficacy of TPEP device in adult patients with chronic hypersecretion]. clinicaltrials.gov/show/NCT00700388 (first received 17 June 2008). VenturelliE , CrisafulliE , DeBiaseA , RighiA , BerighiD , CavicchioliPP , et al. Efficacy of temporary positive expiratory pressure (TPEP) in patients with chronic lung diseases and chronic mucus hypersecretion. The UNIKO project: a multicentre randomised controlled trial. Clinical Rehabilitation2012;27(4):336‐46. ">Venturelli 2012</a>). </p> </li> </ul> </p> <p>We excluded any type of PEP therapy delivered in conjunction with aerosol inhalation.</p> <p>Comparative ACTs could include any of the following techniques, which could be applied in combination. </p> <p> <ul id="CD011699-list-0002"> <li> <p>Gravity‐assisted drainage (GAD), which uses specific positioning of bronchopulmonary segments to facilitate sputum clearance (<a href="./references#CD011699-bbs2-0124" title="PrasadSA . Current concepts in physiotherapy. Journal of the Royal Society of Medicine1993;86(Suppl 20):23‐9. ">Prasad 1993</a>). GAD and manual techniques are often combined as an ACT. Manual techniques, including any combination of percussion, vibration, rib springing, or rib shaking, apply external forces to the chest wall to encourage mobilisation of mucus (<a href="./references#CD011699-bbs2-0090" title="GallonA . The use of percussion. Physiotherapy1992;78:85‐9. ">Gallon 1992</a>; <a href="./references#CD011699-bbs2-0109" title="McCarrenB , AlisonJ . Physiological effects of vibration in subjects with cystic fibrosis. European Respiratory Journal2006;27:1204‐9. ">McCarren 2006</a>). </p> </li> <li> <p>Slow expiration with the glottis open in lateral posture (ELTGOL), which uses GAD with slow expirations performed in a lateral decubitus position (<a href="./references#CD011699-bbs2-0108" title="MartinsJA , Dornelas de AndradeA , BrittoRR , LaraR , ParreiraVF . Effect of slow expiration with glottis opened in lateral posture (ELTGOL) on mucus clearance in stable patients with chronic bronchitis. Respiratory Care2012;57(3):420‐6. ">Martins 2012</a>). </p> </li> <li> <p>Active cycle of breathing technique (ACBT), which utilises a combination of thoracic expansion exercises, breathing control (BC) and the forced expiration technique (FET) to maximise collateral channel ventilation and sputum movement (<a href="./references#CD011699-bbs2-0043" title="PryorJ , WebberB , HodsonM , BattenJ . Evaluation of the forced expiration technique as an adjunct to postural drainage. British Medical Journal1979;18:417‐8. ">Pryor 1979</a>), and which may be applied with or without GAD and manual techniques. </p> </li> <li> <p>Autogenic drainage (AD), which incorporates breathing of variable volume to generate high expiratory flows while minimising airway collapse (<a href="./references#CD011699-bbs2-0130" title="SchoniM . Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis. Journal of the Royal Society of Medicine1989;82:32‐7. ">Schoni 1989</a>). </p> </li> </ul> <ul id="CD011699-list-0003"> <li> <p>Exercise performed for the purpose of sputum clearance, which could include endurance or strength training (<a href="./references#CD011699-bbs2-0085" title="DwyerTJ , AlisonJA , McKeoughZJ , DaviskasE , ByePT . Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis. Chest2011;139(4):870‐7. ">Dwyer 2011</a>). </p> </li> <li> <p>High‐frequency chest wall oscillation, which applies external chest wall oscillations at variable frequencies and intensities through an inflatable vest attached to a machine (<a href="./references#CD011699-bbs2-0138" title="WarwickWJ , HansenLG . The long‐term effect of high frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatric Pulmonology1991;11(3):265‐71. ">Warwick 1991</a>). </p> </li> </ul> </p> <p>We included treatments applied over a single session or on a medium‐term (one to seven days) or longer‐term basis (longer than seven days). </p> </section> <section id="CD011699-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD011699-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011699-list-0004"> <li> <p>HRQOL, measured by disease‐specific, generic, or symptom‐specific questionnaires, which may or may not have been validated in this population. </p> </li> <li> <p>Rate of, duration of, or time to acute exacerbation of bronchiectasis, defined according to symptoms, physician diagnosis, or participant diaries. </p> </li> <li> <p>Incidence of hospitalisation for bronchiectasis.</p> <ul id="CD011699-list-0005"> <li> <p>For stable bronchiectasis, this included time to hospitalisation, number of hospital admissions, or number of hospital days. </p> </li> <li> <p>For acute exacerbation of bronchiectasis, this included length of hospital stay, time to re‐admission, number of hospital admissions, or number of hospital days. </p> </li> </ul> </li> </ul> </p> <p>These could be measured over the short, medium, or longer term according to the time frames previously defined. </p> </section> <section id="CD011699-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes, including physiological outcomes consisted of the following:</p> <p> <ul id="CD011699-list-0006"> <li> <p>Sputum volume (wet and dry weight (g) or volume (mL)). Sputum weight was measured in the short term (within 24 hours of treatment), in the medium term (within one to seven days of treatment) and over the long term (more than seven days of treatment), with successful treatment indicated by an increase in sputum volume. </p> </li> <li> <p>Measures of mucociliary clearance (e.g. radioaerosol clearance).</p> </li> <li> <p>Lung function (e.g. spirometry ‐ forced expiratory volume in one second (FEV<sub>1</sub>), forced vital capacity (FVC), forced expiratory flow (FEF), forced expiratory flow at 25% to 75% of pulmonary volume (FEF<sub>25‐75</sub>), peak expiratory flow rate (PEFR); lung volumes ‐ total lung capacity (TLC), functional residual capacity (FRC), residual volume (RV), inspiratory capacity (IC), TLC/RV ratio. </p> </li> <li> <p>Participant symptoms reported on any scale (dyspnoea or breathlessness, fatigue, discomfort), which may or may not have been validated in this population. </p> </li> <li> <p>Adverse events (pneumothorax, barotrauma, haemoptysis, bronchospasm, nausea).</p> </li> </ul> </p> </section> </section> </section> <section id="CD011699-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011699-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Group Specialised Register (CAGR), which is maintained by the information specialist for the Group. The Register contains trial reports identified from several sources: </p> <p> <ol id="CD011699-list-0007"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), through the Cochrane Register of Studies Online (crso.cochrane.org); </p> </li> <li> <p>Weekly searches of MEDLINE Ovid SP 1946 to date;</p> </li> <li> <p>Weekly searches of Embase Ovid SP 1974 to date;</p> </li> <li> <p>Monthly searches of PsycINFO Ovid SP;</p> </li> <li> <p>Monthly searches of CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature);</p> </li> <li> <p>Monthly searches of AMED EBSCO (Allied and Complementary Medicine);</p> </li> <li> <p>Handsearches of the proceedings of major respiratory conferences.</p> </li> </ol> </p> <p>Studies contained in the Trials Register are identified through search strategies based on the scope of Cochrane Airways. Details of these strategies, as well as a list of handsearched conference proceedings, are in <a href="./appendices#CD011699-sec-0092">Appendix 1</a>. See <a href="./appendices#CD011699-sec-0096">Appendix 2</a> for search terms used to identify studies for this review. </p> <p>We also searched the Physiotherapy Evidence Database (PEDro) using similar terms (<a href="./appendices#CD011699-sec-0097">Appendix 3</a>). </p> <p>We conducted a search of the clinical trials registries ClinicalTrials.gov (www.ClinicalTrials.gov) and the World Health Organization (WHO) trials portal (www.who.int/ictrp/en/). We searched all databases from their inception to February 2017, and we imposed no restriction on language of publication. </p> </section> <section id="CD011699-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We checked reference lists of all primary studies and review articles for additional references. We searched the websites of manufacturers of relevant PEP devices (e.g. Flutter<sup>®</sup>, Acapella<sup>®</sup>, RC‐Cornet<sup>®</sup>, Quaker<sup>®</sup>, Lung Flute<sup>®</sup>) for trial information. </p> </section> </section> <section id="CD011699-sec-0040"> <h3 class="title" id="CD011699-sec-0040">Data collection and analysis</h3> <section id="CD011699-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AL and AB) independently screened titles and abstracts for inclusion of all potential studies identified as a result of the search and coded them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve' (not eligible). We included studies reported as full text, those published as abstract only, and unpublished data when sufficient information was available. We retrieved full‐text study reports/publications, and two review authors (AL and AB) independently screened the full text, identified studies for inclusion, and identified and recorded reasons for exclusion of ineligible studies. We resolved disagreements through discussion, or, if required, we consulted a third person (AH). We calculated the degree of agreement between review authors with a kappa statistic. We identified and excluded duplicates and collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow diagram (<a href="#CD011699-fig-0001">Figure 1</a>) and a 'Characteristics of excluded studies' table (<a href="./references#CD011699-sec-0106" title="">Characteristics of excluded studies</a>). </p> <div class="figure" id="CD011699-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011699-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011699-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form that was piloted on at least one study in the review to record study characteristics and outcome data. Two review authors (AL and AB) extracted the following study characteristics from included studies. </p> <p> <ul id="CD011699-list-0008"> <li> <p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and locations, study setting, withdrawals, date of study. </p> </li> <li> <p>Participants: number, mean age, age range, gender, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria, exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant interventions.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, time points reported.</p> </li> <li> <p>Notes: funding for trial, notable conflicts of interest of trial authors.</p> </li> </ul> </p> <p>Two review authors (AL and AB) independently extracted outcome data from included studies. We noted in the 'Characteristics of included studies' table (<a href="./references#CD011699-sec-0105" title="">Characteristics of included studies</a>) if outcome data were not reported in a useable way. We resolved disagreements by reaching consensus, or by involving a third person (AH). One review author (AL) transferred data into the Review Manager (<a href="./references#CD011699-bbs2-0127" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager (RevMan)</a> file. We double‐checked that data were entered correctly by comparing data presented in the systematic review with those provided in the study reports. A second review author (AB) performed spot‐checks of study characteristics for accuracy against the trial report. We contacted authors of studies to verify extracted data, when necessary, and provided details of missing data when possible. </p> </section> <section id="CD011699-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AL and AB) independently assessed risk of bias for each RCT using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011699-bbs2-0095" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved disagreements by discussion or by involving another review author (AH). We assessed risk of bias according to the following domains. </p> <p> <ul id="CD011699-list-0009"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low, or unclear and provided a quote from the study report, together with a justification for our judgement in the 'Risk of bias' table. We summarised 'risk of bias' judgements across different studies for each of the domains listed. We considered blinding separately for different key outcomes when necessary (e.g. for unblinded outcome assessment, risk of bias for rate of hospitalisation may be very different than for a participant‐reported symptom scale). When information on risk of bias was related to unpublished data or correspondence with a trialist, we noted this in the 'Risk of bias' table. We graded bias as low, high or unclear, and resolved discrepancies by consensus. We summarised results in a 'Risk of bias' table. </p> <p>When considering treatment effects, we considered the risk of bias for studies that contributed to this outcome. </p> <p>For randomised cross‐over trials, additional considerations for risk of bias included appropriateness of cross‐over design, randomisation of treatment order, possibility of carry‐over effects, and availability of unbiased data (<a href="./references#CD011699-bbs2-0095" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <section id="CD011699-sec-0044"> <h5 class="title">Assesment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol and reported deviations from it in the 'Differences between protocol and review' section (<a href="#CD011699-sec-0103">Differences between protocol and review</a>) of the systematic review. </p> </section> </section> <section id="CD011699-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed data for each outcome, irrespective of whether participants were stated to drop out (intention‐to‐treat analysis). We analysed dichotomous data as odds ratios and continuous data as means and standard deviations. We undertook meta‐analyses for continuous data only when this was meaningful (i.e. if treatments, participants and the underlying clinical question were similar enough for pooling to make sense). We calculated mean differences (MDs: same metric scale) or standardised mean differences (SMDs: different metric scale) with 95% confidence intervals (95% CIs). We narratively described skewed data reported as medians and interquartile ranges, where available, or medians and 95% confidence intervals. </p> </section> <section id="CD011699-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed data from HRQOL, symptom questionnaires, lung function, or sputum clearance as continuous or ordinal data. We analysed exacerbation rates or hospitalisations as dichotomous (yes/no) or ratio (frequency, rate) data. We analysed cross‐over trials using generic inverse variance methods, when possible. In the event of inadequate washout for a cross‐over trial, we included only results from the first phase of the trial, where available. One study applied independent t‐tests for a cross‐over trial (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>); as raw data were not available, the results were reported narratively. One study applied a Student's t‐test to compare different techniques (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>); results were reported narratively. </p> </section> <section id="CD011699-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>In the event of missing data, we contacted investigators or study sponsors to verify key study characteristics and to obtain missing numerical outcome data when possible (e.g. when a study was identified as abstract only). When this was not possible, and missing data were related to the intervention, we planned to analyse the impact of including such studies in the overall assessment of results by performing a sensitivity analysis<b>. </b>However, with limited pooling of data, this analysis was not performed. </p> </section> <section id="CD011699-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>Where data was able to be pooled, we used the I² statistic to measure heterogeneity among the trials in each analysis. If we identified substantial heterogeneity (≥ 50%), we would have explored possible causes through prespecified sensitivity analyses. For those studies in which homogeneity was evident, we planned to use a fixed‐effect model for analysis. For studies of substantial heterogeneity (I<sup>2</sup> ≥ 50%), we used a random‐effects model (<a href="./references#CD011699-bbs2-0084" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2008</a>). For those with heterogeneity with an I<sup>2</sup> &gt; 75%, results of included studies were presented in a forest plot, but the pooled estimate was suppressed. </p> </section> <section id="CD011699-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>If we had more than 10 trials, we planned to create a funnel plot and analyse this for small‐study and publication biases (<a href="./references#CD011699-bbs2-0086" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta­analysis detected by a simple, graphical test. BMJ1997;315:629‐34. ">Egger 1997</a>). However, a total of only nine trials were identified in this review. </p> </section> <section id="CD011699-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We analysed separately data from studies related to acute exacerbation compared with studies related to stable bronchiectasis. In addition, we planned to compare studies of low‐ or Hi‐PEP therapy; however no studies using Hi‐PEP therapy were included. Studies providing data on oscillatory PEP therapy were analysed separately. Within each group, we planned to pool data that were clinically homogeneous using a fixed‐effect model; data that were clinically homogeneous using a random‐effects model. However, the differences between interventions and differing units of reporting limited this pooling. We did not pool data that were clinically heterogeneous. </p> <section id="CD011699-sec-0051"> <h5 class="title">'Summary of findings' table</h5> <p>We created a 'Summary of findings' table using the following outcomes: HRQOL, exacerbation rates, and hospitalisation. We used the five GRADE (Grades of Recommendation, Assessment, Development and Evaluation) considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it related to studies that contributed data to the meta‐analyses for prespecified outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011699-bbs2-0095" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>) and GRADEpro software. We justified all decisions to downgrade or upgrade the quality of studies by using footnotes, and we made comments to aid readers' understanding of the review, when necessary. </p> </section> </section> <section id="CD011699-sec-0052"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to carry out the following subgroup analyses:</p> <p> <ul id="CD011699-list-0010"> <li> <p>Oscillatory PEP therapy vs other ACTs.</p> </li> <li> <p>Non‐oscillatory PEP therapy vs other ACTs.</p> </li> <li> <p>Level of PEP (minimal/low pressure ((&lt; 5 cmH<sub>2</sub>0 vs 10 to 25 cm H<sub>2</sub>O) vs high pressure (40 to 120 cm H<sub>2</sub>O)). </p> </li> </ul> </p> <p>We used the following outcomes in subgroup analyses:</p> <p> <ul id="CD011699-list-0011"> <li> <p>HRQOL</p> </li> <li> <p>Exacerbation rates.</p> </li> <li> <p>Hospitalisation rates.</p> </li> </ul> </p> <p>We used the formal test for subgroup interactions in Review Manager (<a href="./references#CD011699-bbs2-0127" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager (RevMan)</a>. </p> </section> <section id="CD011699-sec-0053"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform a sensitivity analysis to determine the effects of methodological quality on the pooled estimate by removing studies that were at high or unclear risk of bias for the domains of blinding and incomplete outcome data. We had planned to examine the effects of the method of diagnosing bronchiectasis (physician‐based or HRCT). However, insufficient numbers of included studies precluded these analyses. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011699-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011699-sec-0054"></div> <section id="CD011699-sec-0055"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011699-sec-0105" title="">Characteristics of included studies</a>, <a href="./references#CD011699-sec-0106" title="">Characteristics of excluded studies</a> and <a href="./references#CD011699-sec-0107" title="">Characteristics of studies awaiting classification</a> for complete details. </p> <section id="CD011699-sec-0056"> <h4 class="title">Results of the search</h4> <p>The 2017 search of databases (CAGR and Pedro) and clinical trial registries of potential studies and reference checks yielded 81 studies. After removal of duplicates, a total of 57 studies were screened. We excluded 39 studies on the basis of title and abstract, including eight which are currently awaiting classification or are ongoing studies; these were not included in the analysis. A total of 18 full‐text studies were assessed for eligibility. We excluded nine studies, as they did not meet the review criteria. We included nine studies in the qualitative analysis. Review authors agreed on 14 out of 18 studies following full‐text review (82%), with kappa = 0.90, indicating substantial agreement. In this review, a total of nine studies were included (<a href="#CD011699-fig-0001">Figure 1</a>). The full details of excluded studies and those awaiting classification are outlined in <a href="./references#CD011699-sec-0106" title="">Characteristics of excluded studies</a> and <a href="./references#CD011699-sec-0107" title="">Characteristics of studies awaiting classification</a> tables. </p> </section> <section id="CD011699-sec-0057"> <h4 class="title">Included studies</h4> <section id="CD011699-sec-0058"> <h5 class="title">Design</h5> <p>This review included seven randomised cross‐over trials (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>) and two randomised controlled trials (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). </p> </section> <section id="CD011699-sec-0059"> <h5 class="title">Participants</h5> <p>The nine included studies involved 213 participants with sample sizes ranging from 10 to 36. Eight studies included clinically stable adult participants (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>) and one study included adult participants experiencing an acute exacerbation of bronchiectasis (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). Bronchiectasis was diagnosed on the basis of HRCT in six studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>;<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>) and by physician diagnosis in two studies, as per the inclusion criteria (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). The study of participants with an acute exacerbation stated inclusion criteria of diagnosis of bronchiectasis of at least one year in duration, with symptoms of cough and sputum production (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). The age range of participants was 46 to 74 years in eight studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>); one study did not report age (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). Of the eight studies in those with stable disease, five reported disease severity according to spirometry, FEV<sub>1</sub> ranged from 53 to 64% predicted (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>) or 0.67 to 0.7 L (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). In those with an acute exacerbation of bronchiectasis, FEV<sub>1</sub> ranged from 36 to 49% predicted (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). </p> </section> <section id="CD011699-sec-0060"> <h5 class="title">Intervention</h5> <p>The duration of each intervention ranged from a single treatment in five studies (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), twice over one week (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>), daily for four weeks (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>) or twice daily for four weeks (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). In those with an acute exacerbation, the frequency was three times per day from day two of admission until day of discharge (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). A washout period of one week was applied in two studies (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>), while three studies did not apply a washout period (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>), one study applied a three hour washout (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), and one study did not mention the use of a washout period (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). Outcome measures were only collected throughout the intervention period, with no long‐term follow‐up beyond the intervention applied in any study. </p> <p>Two studies compared oscillatory PEP therapy (Flutter) to slow expiration with the glottis open from the FRC to the RV, performed in the lateral decubitus position, with the affected lung in the dependent position ('L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral' (ELTGOL) (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>)) with one study adding chest clapping, vibrocompression and coughing (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>). Three studies compared oscillatory PEP therapy (Flutter) to ACBT (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>), with two studies applying ACBT in a seated (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>) or a GAD position (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>) or both. One study compared oscillatory PEP therapy (Flutter) to GAD with BC, deep inspiration, relaxation, and coughing (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). One study applied oscillatory PEP therapy (Acapella) in a GAD position versus ACBT with GAD (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). One study compared minimal PEP therapy to AD and to ELTGOL (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). One study compared oscillatory PEP therapy (Acapella) to AD (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). </p> </section> <section id="CD011699-sec-0061"> <h5 class="title">Outcome measures</h5> <p>Eight studies included a measure of sputum volume or weight, which could be wet or dry, and a measure of spirometry (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>;<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). Health‐related quality of life was assessed using the Short‐Form‐36 (SF‐36) (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>) or the Chronic Respiratory Questionnaire (CRQ) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>), while cough‐related quality of life was assessed with the Leicester Cough Questionnaire (LCQ) in one study (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Breathlessness was measured using the Borg scale in four studies (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), while the Medical Research Council score for Dyspnoea (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>) and the 15‐count breathlessness score (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>) were each applied in one study. Symptoms of tiredness and discomfort (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>) and coughing (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>) were assessed in one study each. Lung function was measured in seven studies, with spirometry (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>;<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>), peak expiratory flow (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), and lung volumes included (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>). </p> </section> </section> <section id="CD011699-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded a total of 48 studies. Reasons for exclusion of full‐text reviewed studies were comparison between two types of PEP therapy (n = 2), mixed disease group from which data related to bronchiectasis could not be extracted (n = 2), mixed therapy group from which data related to PEP therapy could not be extracted (n = 2), lack of PEP therapy use (n = 1), lack of randomisation (n = 1) and lack of comparison group (n = 1). Full details of reasons for exclusion are provided in the <a href="./references#CD011699-sec-0106" title="">Characteristics of excluded studies</a> table. A further six studies are ongoing (<a href="./references#CD011699-sec-0108" title="">Characteristics of ongoing studies</a>) and two are awaiting classification. These will be assessed for eligibility in further updates of this review. </p> </section> </section> <section id="CD011699-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias was able to be completed for eight studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). One study was available only in abstract form, therefore all criteria for 'risk of bias' assessment were indicated as unclear (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). An overview of the risk of bias for the domains listed below is outlined in <a href="#CD011699-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011699-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011699-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011699-sec-0064"> <h4 class="title">Allocation</h4> <p>All studies reported random allocation to groups, but the methods by which this was applied were stated in only four studies (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Five studies stated the use of either sealed, opaque envelopes, or a method of concealment was used for allocation (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>); three studies did not provide sufficient information to determine the method used (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). </p> </section> <section id="CD011699-sec-0065"> <h4 class="title">Blinding</h4> <p>Insufficient information was provided in seven studies regarding the blinding of participants and personnel delivering the interventions (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), while three studies specifically stated the absence of blinding of personnel (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>) and participants and personnel (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). The physical nature of the intervention is likely to impose limits on blinding participants in these studies. One study stated the use of an independent assessor for recording pre and post treatment outcome measures (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). Insufficient data were available to show whether assessors were blinded in other studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>;<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). No studies reported whether data analysts were blinded to group allocation. </p> </section> <section id="CD011699-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Three studies stated withdrawal of participants (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). One study outlined that three participants were unable to conclude the study and their results were not included in the analysis (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>). Thompson stated that of the five participants who withdrew, three dropped out because of an infective exacerbation (two during the oscillatory PEP therapy arm and one during the ACBT arm) and two recorded insufficient data for analysis (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). The third study outlined that two participants dropped out due to acute low back pain and pulmonary exacerbation (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). The data of withdrawn participants were not included in analysis in any study (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). </p> </section> <section id="CD011699-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Three studies were reported on a clinical registry prospectively (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Results were reported for all outcomes at each time point for six studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>;<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). With one study reporting only in abstract form, it is possible that not all data were reported in this study (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). </p> </section> <section id="CD011699-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>An adequate washout period of one week was applied in two studies (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). No washout period was applied in three studies (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>), which may have influenced the findings of two studies, with consecutive days of treatment applied in one study (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>) and a four‐week intervention applied in another study (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). One study used a three‐hour washout period between interventions, which may have influenced findings (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). One study did not mention the inclusion of a washout period between interventions (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). </p> </section> </section> <section id="CD011699-sec-0069"> <h3 class="title" id="CD011699-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD011699-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>See Summary of findings (<a href="./full#CD011699-tbl-0001">summary of findings Table for the main comparison</a>) for the primary outcome comparisons. We were able to include data from nine studies, in a quantitative and narrative synthesis, with all studies conducted in the adult population (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>;). </p> <section id="CD011699-sec-0070"> <h4 class="title">Primary outcomes</h4> <section id="CD011699-sec-0071"> <h5 class="title">Health‐related quality of life</h5> <p>Three studies examined the effects of PEP therapy compared to other techniques on HRQOL (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Due to clinical heterogeneity in comparison of treatment techniques, follow‐up, and outcome measures, no studies could be combined in meta‐analysis. Using oscillatory PEP therapy (Flutter) daily for four weeks improved general health (P = 0.048) based on the SF‐36 compared to daily ACBT (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). Minimal PEP, AD, and ELTGOL, when applied for three sessions over one week, all significantly increased (better) cough‐related quality of life according to the LCQ total scores, with no difference between minimal PEP therapy and AD (median 0.4 (95% CI 0.1 to 1.2) vs 0.5 (95% CI 0.1 to 0.5)) or minimal PEP therapy and ELTGOL (median 0.4 (95% CI 0.5 to 2.1) vs 0.9 (95% CI 0.1 to 1.2)) (P = 0.60) (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Performing oscillatory PEP therapy (Flutter) compared to ACBT in a GAD position twice daily for four weeks had a similar effect on HRQOL for dyspnoea (MD 0.01, 95% CI ‐0.48 to 0.50; one study, 17 participants, low‐quality evidence) (<a href="./references#CD011699-fig-0004" title="">Analysis 1.1</a>), fatigue (MD ‐0.19, 95% CI ‐0.82 to 0.45; one study, 17 participants, low‐quality evidence) (<a href="./references#CD011699-fig-0005" title="">Analysis 1.2</a>), emotional function (MD ‐0.06, 95% CI ‐0.63 to 0.52; one study, 17 participants, low‐quality evidence) (<a href="./references#CD011699-fig-0006" title="">Analysis 1.3</a>), mastery (MD ‐0.10, 95% CI ‐0.65 to 0.46; one study, 17 participants, low‐quality evidence) (<a href="./references#CD011699-fig-0007" title="">Analysis 1.4</a>) and total score (MD ‐0.09, 95% CI ‐0.37 to 0.19; one study, 17 participants, low‐quality evidence) (<a href="./references#CD011699-fig-0008" title="">Analysis 1.5</a>) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). The results of all studies are outlined in <a href="#CD011699-tbl-0002">Table 1</a>. </p> <div class="table" id="CD011699-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Individual study outcomes for HRQOL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Disease‐specific QOL</b> </p> <p>Dyspnoea domain: MD 0.01 (95% CI ‐0.48 to 0.50)</p> <p>Fatigue domain: MD ‐0.19 (95% CI ‐0.82 to 0.45)</p> <p>Emotional function domain: MD ‐0.06 (95% CI ‐0.63 to 0.52)</p> <p>Mastery domain: MD ‐0.10 (95% CI ‐0.65 to 0.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs ACBT (daily for 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Improved general health on SF‐36 (P = 0.048) with PEP therapy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs AD</p> <p>Minimal PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cough‐related quality of life (LCQ)</b> </p> <p>median 0.4 (95% CI 0.1 to 1.2) vs 0.5 (95% CI 0.1 to 0.5)</p> <p>median 0.4 (95% CI 0.5 to 2.1) vs 0.9 (95% CI 0.1 to 1.2)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; CI ‐ confidence interval; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; LCQ ‐ Leicester cough questionnaire; MD ‐ mean difference; PEP ‐ positive expiratory pressure; QOL ‐ quality of life; SF‐36 ‐ short form 36. </p> </div> </div> </section> <section id="CD011699-sec-0072"> <h5 class="title">Rate of exacerbation or time to first exacerbation</h5> <p>No studies reported on the rate of or time to first exacerbation.</p> </section> <section id="CD011699-sec-0073"> <h5 class="title">Incidence of hospitalisation</h5> <p>No studies reported on the incidence of hospitalisation for those in a stable clinical state. </p> </section> </section> <section id="CD011699-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD011699-sec-0075"> <h5 class="title">Sputum volume or weight</h5> <p>Eight studies compared the effects of PEP therapy to other ACTs on sputum yield (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). Two studies investigating a single session of oscillatory PEP therapy (Acapella or Flutter) compared to GAD with ACBT are presented together, but due to significant clinical heterogeneity, a pooled estimate of results was not calculated. A single session of oscillatory PEP therapy (Acapella) produced a similar sputum weight compared to GAD with ACBT (SMD 0.54 g, 95% CI ‐0.38 to 1.46 g; 20 participants); while a single session of oscillatory PEP therapy (Flutter) produced less sputum compared to GAD with ACBT (SMD 5.6 g (95% CI 2.91 to 8.29 g; 36 participants) (<a href="./references#CD011699-fig-0009" title="">Analysis 2.1</a>) (<a href="#CD011699-fig-0003">Figure 3</a>). Less sputum volume was produced with oscillatory PEP therapy (Flutter) compared to GAD with ACBT (MD 5.1 mL (95% CI 2.24 to 7.96 mL; one study, 36 participants) (<a href="./references#CD011699-fig-0010" title="">Analysis 2.2</a>) (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). There was no difference in sputum weight between oscillatory PEP therapy (Flutter) and ACBT in a seated position (MD ‐0.3 g (95% CI ‐1.42 to 0.82 g; one study, 36 participants) (<a href="./references#CD011699-fig-0013" title="">Analysis 3.1</a>) or in sputum volume (MD ‐0.60 mL, 95% CI ‐1.87 to 0.67 mL; one study, 36 participants) (<a href="./references#CD011699-fig-0014" title="">Analysis 3.2</a>) (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). A single treatment of oscillatory PEP therapy (Flutter) yielded a lower sputum weight compared to ELTGOL (median 0.15 g (minimum to maximum 0.05 to 0.13 g) versus median 0.38 (minimum to maximum 0.06 to 2.63 g; one study, 10 participants), P &lt; 0.05) (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>). Less sputum was expectorated during a single treatment of minimal PEP therapy compared to AD (median difference 3.1 g, 95% CI 1.5 to 4.8 g) or ELTGOL (MD 3.6 g, 95% CI 2.8 to 7.1 g; one study, 31 participants) (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). However, mean clearance over 24 hours was similar for each of these techniques (P = 0.8) (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). A comparison of AD to oscillatory PEP therapy (Acapella) did not yield a difference in sputum volume (mean 16.1 mL (SD 7.9) vs 16.3 mL (10.3), P = 0.92) or sputum weight (mean 15.8 g (5.7) vs 16.2 g (7.9) (P = 0.85) immediately post treatment (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). Comparing four sessions of oscillatory PEP therapy (Flutter) to ELTGOL, there was no significant difference in average sputum dry weight per session (0.28 g (SD 0.28) vs 0.16 g (0.06), P &lt; 0.05 or wet weight (7.2 g (SD 2.3) vs 6.3 g (0.7), P &gt; 0.05) (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>). Four weeks of twice daily oscillatory PEP therapy compared to ACBT with GAD did not increase sputum weight (median difference 7.64 g, P = 0.77) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). When applied during an acute exacerbation, oscillatory PEP therapy (Flutter) and GAD yielded a similar sputum weight on day two of admission (MD favouring GAD 19.86 g, 95% CI ‐7.95 to 47.67 g; one study, 10 participants) (<a href="./references#CD011699-fig-0017" title="">Analysis 4.1</a>), day four of admission (MD 22.46 favouring GAD, 95% CI ‐10.71 to 55.63 g; one study, 10 participants) (<a href="./references#CD011699-fig-0018" title="">Analysis 4.2</a>) or day of discharge (MD favouring GAD, 21.03 g 95% CI ‐11.29 to 53.35 g; one study, 10 participants) (<a href="./references#CD011699-fig-0019" title="">Analysis 4.3</a>) (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>).The results of all studies are outlined in <a href="#CD011699-tbl-0003">Table 2</a>. </p> <div class="figure" id="CD011699-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: Oscillatory PEP therapy vs ACBT with GAD (single session), Sputum weight (g)" data-id="CD011699-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: Oscillatory PEP therapy vs ACBT with GAD (single session), Sputum weight (g) </p> </div> </div> </div> <div class="table" id="CD011699-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Individual study outcomes for sputum yield</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dry weight (MD 0.28 g (SD 0.28) vs 0.16 g (0.06)), P &gt; 0.05</p> <p>wet weight (MD 7.2 g (SD 2.3) vs 6.3 g (0.7)), P &gt; 0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median difference 7.64 g, P = 0.77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2: MD 19.86 g (95% CI ‐7.95 to 47.67)</p> <p>Day 4: MD 22.46 g (95% CI ‐10.71 to 55.63)</p> <p>Day of discharge: MD 21.03 g (95% CI ‐11.29 to 53.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.54 g (95% CI ‐0.39 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.3 g (95% CI ‐1.42 to 0.82)</p> <p>MD ‐5.6 g (95% CI ‐10.1 to ‐1.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 0.15 g (minimum to maximum 0.05 to 0.13 g) vs 0.38 g (0.06 to 2.63 g)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs AD</p> <p>Minimum PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median difference 3.1 g (95% CI 1.5 to 4.8 g)</p> <p>median difference 3.6 g (95% CI 2.8 to 7.1 g)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 15.8 g (SD 5.7) vs 16.2 g (7.9)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique<sub>;</sub> AD ‐ autogenic drainage; CI ‐ confidence interval; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; g ‐ grams; GAD ‐ gravity assisted drainage; MD ‐ mean difference; PEP ‐ positive expiratory pressure; SD ‐ standard deviation. </p> </div> </div> </section> <section id="CD011699-sec-0076"> <h5 class="title">Sputum clearance</h5> <p>No studies reported on sputum clearance using radioaerosol clearance.</p> </section> <section id="CD011699-sec-0077"> <h5 class="title">Lung function</h5> <p>Eight studies compared the effects of PEP therapy to other ACTs on measures of lung function (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). None could be combined in meta‐analysis due to clinical heterogeneity. A single treatment session of oscillatory PEP therapy (Acapella) and ACBT with GAD yielded a similar effect on FEV<sub>1</sub>, FVC and PEF % predicted (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). There was no difference in lung function (FEV<sub>1</sub>, FVC, FEF<sub>25‐75</sub>) at treatment conclusion between minimal PEP therapy and ELTGOL or minimal PEP therapy and AD (P &gt; 0.05) (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Similarly, a single session of oscillatory PEP therapy (Acapella) compared to AD did not change PEFR immediately following treatment (176.1 L/min (72.6) vs 179.1 L/min (72.6), P = 0.87) (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). There was no difference in PEFR between oscillatory PEP therapy (Flutter) vs ELTGOL between four occasions of treatment (P &gt; 0.05) (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>). One session of oscillatory PEP therapy (Flutter) had a similar effect to ELTGOL on change in FEV<sub>1</sub> (median 1.6 L (minimum to maximum ‐6.8 to 21.4) vs median 2.2 L (‐20.2 to 20.9)), change in FVC (median 2.44 L (minimum to maximum ‐3.9 to 8.1) vs median 0.96 L (‐11.8 to 22.1)), change in FEV<sub>1</sub>/FVC (median 0.7 L (minimum to maximum ‐11.3 to 19.6) vs median 0 L (‐8.6 to 10.6)), change in FEF<sub>25‐75</sub> (median 4.5 L (minimum to maximum ‐21.4 to 160) vs median 6 L (‐90.51 to 236)), change in IC (median 3.49 L (minimum to maximum ‐28.47 to 33.78) vs median 2.65 L (‐15.65 to 27.66)), change in TLC (median ‐18.27 L (minimum to maximum ‐42.83 to ‐6.43) vs median 9.66 L (‐40.03 to ‐1.96)), change in FRC (median ‐25.81 L (minimum to maximum ‐52.02 to ‐5.14) vs median ‐14.48 L (‐55.65 to ‐3.6)), change in RV (median ‐29.55 L (minimum to maximum ‐54.66 to ‐8.86) vs median ‐18.72 L (‐71.85 to ‐10.73)) or change in RV/TLC ratio (median ‐5.21 L (minimum to maximum ‐22.81 to 27.59) vs median ‐8.48 L (‐25.46 to 113.04)) (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>). Four weeks of treatment with oscillatory PEP therapy (Flutter) compared to ACBT with GAD did not affect PEFR for the morning session (median difference ‐2.5 L/min, P = 0.38) or the evening session (median ‐2.72 (95% CI ‐6.95 to 1.52), P = 0.30) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). Four weeks of daily ACBT or oscillatory PEP therapy (Flutter) did not yield a difference in FEV<sub>1</sub> or FVC between techniques (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). </p> <p>During an acute exacerbation, there was no difference in FEV<sub>1</sub> post treatment between oscillatory PEP therapy (Flutter) and GAD on day two of admission (MD 0.12 L (95% ‐0.32 to 0.56 L)) (<a href="./references#CD011699-fig-0020" title="">Analysis 4.4</a>), day four (MD 0.15 L (95% CI ‐0.27 to 0.57 L)) (<a href="./references#CD011699-fig-0021" title="">Analysis 4.5</a>) or day of discharge (MD 0.12 L (95% CI ‐0.52 to 0.76 L)) (<a href="./references#CD011699-fig-0022" title="">Analysis 4.6</a>) (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). Similarly, there was no difference between these interventions for FVC on day two of admission (MD ‐0.22 L (95% CI ‐0.81 to 0.37 L)) (<a href="./references#CD011699-fig-0023" title="">Analysis 4.7</a>), Day four of admission (MD 0.2 L (95% CI ‐0.48 to 0.88 L)) (<a href="./references#CD011699-fig-0024" title="">Analysis 4.8</a>) or day of discharge (MD 0.12 L (95% CI ‐0.52 to 0.76 L)) (<a href="./references#CD011699-fig-0025" title="">Analysis 4.9</a>). Equivalent results were evident for PEFR for day two (MD 22.2 L/min (95% CI ‐48.88 to 93.28 L/min)) (<a href="./references#CD011699-fig-0026" title="">Analysis 4.10</a>), day four (MD 22.6 L/min (95% CI ‐40.69 to 85.89 L/min)) (<a href="./references#CD011699-fig-0027" title="">Analysis 4.11</a>) and day of discharge (MD 23.2 L/min (95% CI ‐39.56 to 85.96 L/min)) (<a href="./references#CD011699-fig-0028" title="">Analysis 4.12</a>) (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>).The results of all studies are outlined in <a href="#CD011699-tbl-0004">Table 3</a>. </p> <div class="table" id="CD011699-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Individual study outcomes for lung function</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 1 PEFR: mean 405 L/min (SD 157) vs 439 L/min (175)</p> <p>Day 2 PEFR: 434 L/min(150) vs 417 L/min (134)</p> <p>Day 3 PEFR: 428 L/min(166) vs 419 L/min (157)</p> <p>Day 4 PEFR: 456 L/min(159) vs 462 L/min (185)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PEFR morning: median difference ‐2.5 L/min, P = 0.38)</p> <p>PEFR evening: median difference ‐2.72 L/min (95% CI ‐6.95 to 1.52), P = 0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2 FEV<sub>1</sub>: MD 0.12 L (95% ‐0.32 to 0.56) </p> <p>Day 4 FEV<sub>1</sub>: MD 0.15 L (95% CI ‐0.27 to 0.57) </p> <p>Day of discharge FEV<sub>1</sub>: (MD 0.12 L (95% CI ‐0.52 to 0.76) </p> <p>Day 2 FVC: MD ‐0.22 L (95% CI ‐0.81 to 0.37)</p> <p>Day 4 FVC: MD 0.2 L (95% CI ‐0.48 to 0.88)</p> <p>Day of discharge: FVC MD 0.12 L (95% CI ‐0.52 to 0.76)</p> <p>Day 2 PEFR: MD 22.2 L/min (95% CI ‐48.88 to 93.28)</p> <p>Day 4 PEFR: MD 22.6 L/min (95% CI ‐40.69 to 85.89)</p> <p>Day of discharge PEFR: MD 23.2 L/min (95% CI ‐39.56 to 85.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>: mean (SD) 65 (22) % predicted vs 65 (22) </p> <p>FVC: 81 (20) % predicted vs 81 (20)</p> <p>PEF: 68 (19) L/min vs 70 (18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference between techniques, MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>: median 1.6 L (minimum to maximum ‐6.8 to 21.4) vs 2.2 L (‐20.2 to 20.9) </p> <p>FVC: median 2.44 L (minimum to maximum ‐3.9 to 8.1) vs 0.96 L (‐11.8 to 22.1)</p> <p>FEV<sub>1</sub>/FVC: median 0.7 L (minimum to maximum ‐11.3 to 19.6) vs 0.0 L (‐8.6 to 10.6) </p> <p>FEF<sub>25‐75</sub>: median 4.5 L (minimum to maximum ‐21.4 to 160.0) vs 6.0 (‐90.51 to 236) </p> <p>Change in IC: median 3.5 L (minimum to maximum 28.5 to 33.8) vs 2.7 (‐15.7 to 27.7)</p> <p>Change in TLC: median ‐18.3 L (minimum to maximum ‐42.4 to ‐6.4) vs 9.7 (‐40.0 to ‐1.9) </p> <p>Change in FRC: median ‐25.8 L (minimum to maximum ‐52.0 to ‐5.1) vs ‐14.5 L (‐55.7 to ‐3.6) </p> <p>Change in RV (median ‐29.6 L (minimum to maximum ‐54.7 to ‐8.9) vs ‐18.7 L (‐71.9 to ‐10.7) </p> <p>Change in RV/TLC ratio (median ‐5.2 L (minimum to maximum ‐22.8 to 27.6) vs ‐8.5 L (‐25.5 to 113.0) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>, FVC, FEF<sub>25‐75</sub> remain unchanged between techniques, MD NR, P &gt; 0.05 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PEFR: mean 176.1 L/min (SD 72.6) vs 179.1 (72.6), P = 0.87</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; FEF 25‐75 ‐ forced expiratory flow at 25 to 75% of forced vital capacity; FEV<sub>1</sub> ‐ forced expiratory volume in one second; FRC ‐ functional residual capacity; FVC ‐ forced vital capacity; GAD ‐ gravity assisted drainage; IC ‐ inspiratory capacity; L ‐ litres; L/min ‐ litres per minute; MD ‐ mean difference; NR ‐ not reported; PEFR ‐ peak expiratory flow rate; <sub>PEP ‐ positive expiratory pressure; RV ‐ residual volume; SD ‐ standard deviation;</sub> TLC ‐ total lung capacity. </p> </div> </div> </section> <section id="CD011699-sec-0078"> <h5 class="title">Symptoms</h5> <p>A single session of oscillatory PEP therapy (Flutter), when compared to ACBT with GAD, generated a similar level of fatigue (MD ‐0.3, 95% CI ‐0.35 to 0.95) (<a href="./references#CD011699-fig-0011" title="">Analysis 2.3</a>). However, using the Flutter was more tiring compared to ACBT alone (MD 0.7, 95% CI 0.15 to 1.25) (<a href="./references#CD011699-fig-0015" title="">Analysis 3.3</a>) (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). There was no difference in discomfort level between the Flutter compared to ACBT alone (MD 0.40, 95% CI ‐0.12 to 0.92) (<a href="./references#CD011699-fig-0016" title="">Analysis 3.4</a>), or between Flutter and ACBT combined with GAD (MD ‐0.3, 95% CI ‐0.82 to 0.22) (<a href="./references#CD011699-fig-0012" title="">Analysis 2.4</a>) (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). Similarly, there was no difference in dyspnoea (Borg score) between oscillatory PEP therapy (Acapella) and AD (mean 1.8 (SD 1.1) vs 1.8 (1.2), P = 1.00) (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>) or in a comparison of oscillatory PEP therapy (Flutter) vs ACBT or ACBT with GAD (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). The 15‐count breathlessness score did not differ between a single session of oscillatory PEP therapy (Acapella) and ACBT with GAD (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). Four weeks of daily oscillatory PEP therapy (Flutter) compared to ACBT had a similar effect on the degree of dyspnoea (Borg score), and symptoms of cough and feelings of weakness when compared to ACBT (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). Four weeks of twice daily oscillatory PEP therapy (Flutter) generated similar levels of breathlessness following morning therapy session (MD 0.13, 95% CI ‐0.078 to 0.34), P = 0.36) and evening sessions (median difference ‐0.04, P &gt; 0.99) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>).The results of all studies are outlined in <a href="#CD011699-tbl-0005">Table 4</a>. </p> <div class="table" id="CD011699-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Individual study outcomes for symptoms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Borg dyspnoea scale morning: MD 0.13 (95% CI ‐0.078 to 0.34), P = 0.36</p> <p>Borg dyspnoea scale evening: median difference ‐0.04, P &gt; 0.99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15‐count breathlessness score: MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue: MD ‐0.3 points (95% CI ‐0.35 to 0.95)</p> <p>Discomfort: MD ‐0.3 points (95% CI ‐0.82 to 0.22)</p> <p>Fatigue: MD 0.7 points (95% CI 0.15 to 1.25)</p> <p>Discomfort: MD 0.40 points (95% CI ‐0.12 to 0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Borg and Medical Research Council scores: no difference between techniques, MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 1.8 (SD 1.1) vs 1.8 (1.2), P = 1.00</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; CI ‐ confidence interval; GAD ‐ gravity assisted drainage; MD ‐ mean difference; NR ‐ not reported; PEP ‐ positive expiratory pressure. </p> </div> </div> </section> <section id="CD011699-sec-0079"> <h5 class="title">Adverse events</h5> <p>One study reported the occurrence of nausea in one participant when using oscillatory PEP therapy (Flutter) (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). No other reports of adverse events were made from other studies; it is unknown if any adverse events occurred in these studies. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011699-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011699-sec-0080"></div> <section id="CD011699-sec-0081"> <h3 class="title" id="CD011699-sec-0081">Summary of main results</h3> <p>This review compared the effects of PEP therapy to other forms of ACTs in individuals with bronchiectasis. Results from nine studies of 213 individuals were mixed. In individuals with stable bronchiectasis, data from a small number of studies illustrated that PEP therapy offered similar effects on HRQOL, cough‐related quality of life and symptoms of breathlessness as other ACTs. Short and medium‐term use of PEP therapy offered no greater advantage in sputum expectoration compared to other types of techniques, irrespective of clinical disease state. No difference in effects on measures of lung function were evident between PEP therapy and other ACTs. According to the GRADE criteria, all review outcomes were rated as low‐quality. Future, longer term studies are required to confirm the magnitude of effect on HRQOL, exacerbation frequency, and hospitalisation rates. Further information is needed regarding the effect of PEP therapy during an acute exacerbation of bronchiectasis. </p> </section> <section id="CD011699-sec-0082"> <h3 class="title" id="CD011699-sec-0082">Overall completeness and applicability of evidence</h3> <p>Key clinical features of bronchiectasis are cough, fatigue, and breathlessness (<a href="./references#CD011699-bbs2-0099" title="KingPT , HoldsworthSR , FreezerNJ , VillanuevaE , HolmesPW . Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respiratory Medicine2006;100:2183‐9. ">King 2006</a>); for this reason, a reduction in these symptoms is beneficial. It is therefore encouraging that minimal PEP therapy, AD, and ELTGOL lead to improvement in cough‐related quality of life, even when used for a short duration (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). This is despite each of these techniques differing in their underlying rationale. The proposed physiological basis for ELTGOL is the promotion of two‐phase gas‐liquid interaction to facilitate mucociliary clearance (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>), while the proposed primary mechanism of oscillatory PEP therapy involves a splinting effect on the airways to improve collateral ventilation and altering sputum rheology (<a href="./references#CD011699-bbs2-0054" title="TambascioJ , DeSouzaLT , LisboaRM , PassarelliRDCV , SouzaHCDD , GastaldiAC . The influence of flutter®VRP1 components on respiratory secretion transport of patients with bronchiectasis. American Journal of Respiratory and Critical Care Medicine2011;183:A6410. TambascioJ , DeSouzaLT , LisboaRMh , PassarelliRDCV , DeSouzaHCD , GastaldiAC . The influence of Flutter VRP1 components of mucus transport of patients with bronchiectasis. Respiratory Medicine2011;105:1316‐21. ">Tambascio 2011</a>). In contrast, AD relies on the generation of shearing forces induced by airflow at different lung volumes to loosen and mobilise secretions (<a href="./references#CD011699-bbs2-0130" title="SchoniM . Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis. Journal of the Royal Society of Medicine1989;82:32‐7. ">Schoni 1989</a>). This suggests that, regardless of the type of technique, use of either PEP therapy, AD, or ELTGOL may lead to more efficient expectoration in the short term. However, with a lack of sustained improvement following the washout period between treatment techniques, improvement in this domain of quality of life may only be able to be maintained with regular treatment. </p> <p>The degree of breathlessness was not greater with PEP therapy compared to other techniques, including AD or ACBT with GAD (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>). Although not specifically stated, this may be related to the approach with these techniques, with the inclusion of sessions of breathing control (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>). However, for those experiencing fatigue, use of oscillatory PEP with a Flutter may be less tiring compared to ACBT in a seated position (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). The reason for this is unclear, with both techniques undertaken in a seated position. It is possible that a greater degree of breathing control was incorporated into the performance of ACBT, but in the absence of a specific description of the PEP therapy, this finding should be interpreted with caution. The lack of difference in disease‐specific HRQOL between oscillatory PEP therapy and ACBT with GAD (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>) suggests that any type of ACT may offer equal benefit in HRQOL. Evaluating the effects of ACTs on HRQOL is difficult with a treatment duration of only four weeks; a longer length of time of six or 12 months is required to fully evaluate treatment effect. With reports of greater preference for independent techniques such as oscillatory PEP therapy (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>), longer term studies which factor in adherence would provide a clearer indication of the effect on HRQOL. In addition, alternative options for evaluating HRQOL have now been developed for bronchiectasis and which specifically consider all clinical symptoms which are of importance to people with this condition (<a href="./references#CD011699-bbs2-0126" title="QuittnerAL , O'DonnellA , SalatheM , LewisS , MontgomeryA , O'RiordanT , et al. Quality of life questionnaire‐Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax2015;70(1):12‐20. ">Quittner 2015)</a>. Including this tool as an outcome measure in future studies of PEP therapy and other ACTs may provide more definitive information. Experiencing less pain with oscillatory PEP therapy is likely to influence adherence. However, with this study only available in abstract form and the lack of detail in location of pain (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>), this finding requires further clarification. Using PEP therapy compared to GAD during an acute exacerbation offers no additional advantage in the duration of hospital stay. With the lack of studies including exacerbation rates and hospitalisation rates, there is a need of further long‐term research which incorporate these clinically important outcomes. </p> <p>The effect on sputum expectoration is variable, with some single treatments with oscillatory PEP therapy (either Flutter or Acapella) producing less sputum expectoration compared to GAD with ACBT or with AD or ELTGOL (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>), while other studies found no difference in the use of oscillatory PEP therapy and ACBT, with or without GAD, AD, or GAD with chest clapping and vibrocompression and coughing (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), irrespective of clinical state. Reasons for these contrasting findings are likely to be related to the differences in treatment approaches as well as the duration of treatment sessions. Greater sputum expectoration in a single session or with four weeks of daily treatment with ACBT and GAD compared to oscillatory PEP therapy was achieved only when the selection of GAD positions was based on HRCT results (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>), rather than right and left lateral decubitus positions or two positions based on unknown criteria (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). This may be an important factor when choosing between PEP therapy and ACBT with GAD and the approach adopted in position selection. The addition of chest clapping and vibrocompression offered no greater advantage over oscillatory PEP therapy (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>). However, as ACBT and GAD are perceived to be more time‐consuming (<a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>), the degree of interference in daily life may be an important clinical consideration. If GAD is not included, equivalent benefits for sputum production were achieved with ACBT in a seated position or oscillatory PEP therapy (Flutter). This illustrates the role of patient preference, with oscillatory PEP therapy a well accepted and preferable technique to patients with bronchiectasis (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>). </p> <p>The greater sputum weight immediately post treatment achieved with ELTGOL over oscillatory PEP therapy (Flutter) or minimal PEP highlight that the components of ELTGOL may be of greater advantage. In one study of ELTGOL, participants performed slow expirations with an open glottis from FRC to RV in a lateral decubitus positions while oscillatory PEP therapy was undertaken in a seated position also for 15 minutes (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>). <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> applied ELTGOL and compared this to minimal PEP therapy, with each session lasting 40 minutes. However, with the difference in sputum weight in one study being only 0.23 g (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>) and in the second 3.6 g (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>), the clinical significance of these findings is unclear. However, it should be noted that differing approaches to sputum expectoration were applied between these two studies. Prior to any intervention, a series of five minutes of voluntary coughing was administered to all participants to clear central airway secretions (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>); this approach was not used in the study conducted by <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>. Although clearance of central secretions prior to commencing ACTs may provide a more accurate estimate of the effectiveness of a specific ACT upon sputum expectoration and could avoid an overestimation of the impact of the technique, it is a challenge to directly image the airways and determine whether secretions are originating from peripheral or central airways. Further studies could employ similar methods to allow direct comparison of techniques. The lack of difference in sputum clearance over a 24 hour period between ELTGOL and minimal PEP therapy may be related to a slower action timing for minimal PEP therapy in sputum clearance, with only 28% of sputum cleared during the physiotherapy session compared to 42% for ELTGOL (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). The amount of pressure applied in PEP therapy may also influence sputum expectoration. Minimal PEP generated pressure of 1 cmH<sub>2</sub>O rather than 10 to 25 cmH<sub>2</sub>O reached with PEP therapy or oscillatory PEP therapy (<a href="./references#CD011699-bbs2-0088" title="FalkM , KelstrupM , AndersenJ , KinoshitaT , FalkP , StøvringS , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. European Journal of Respiratory Disease1984;65:423‐32. ">Falk 1984</a>; <a href="./references#CD011699-bbs2-0083" title="DarbeeJ , OhtakeP , GrantB , CernyFJ . Physiological evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. Physical Therapy2004;84:524‐37. ">Darbee 2004</a>). This may be insufficient to promote airflow through collateral ventilation and allow an increased volume of air behind secretions which supports sputum movement towards the larger airways (<a href="./references#CD011699-bbs2-0088" title="FalkM , KelstrupM , AndersenJ , KinoshitaT , FalkP , StøvringS , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. European Journal of Respiratory Disease1984;65:423‐32. ">Falk 1984</a>; <a href="./references#CD011699-bbs2-0135" title="Van derSchansC , Van derMarkT , DeVriesG , PiersDA , BeekhuisH , Dankert‐RoelseJE , et al. Effect of positive expiratory pressure breathing in patients with cystic fibrosis. Thorax1991;46:252‐6. ">Van der Schans 1991</a>). This degree of pressure may account for the contrasting findings between studies comparing AD and PEP therapy. Comparing AD and oscillatory PEP therapy, a similar sputum volume is achieved after four weeks of treatment (<a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), while a single session of minimal PEP therapy yielded less expectoration during a physiotherapy session (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Although exacerbations of bronchiectasis are characterised by an increase in sputum production, both oscillatory PEP therapy and GAD appear to be equally effective (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>); this emphasises the value in considering patient preference for technique in this clinical state. A confounding factor is the difference between studies in the measurement of sputum expectoration, with five studies using wet weight/volume (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>), one study using dry weight <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>), one using wet and dry weight (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>) and one not stated (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>). Wet volume may be influenced by an individual's reluctance to expectorate, saliva contamination and the swallowing of secretions (<a href="./references#CD011699-bbs2-0141" title="WilliamsM . Chest physiotherapy and cystic fibrosis: why is the most effective form of treatment still unclear?. Chest1994;106(6):1872‐82. ">Williams 1994</a>). Contamination with saliva may be corrected by drying sputum and measuring dry weight (<a href="./references#CD011699-bbs2-0072" title="BoucherRC . Bronchiectasis: a continuum of ion transport dysfunction or multiple hits?. American Journal of Respiratory and Critical Care Medicine2010;181:1017‐9. ">Boucher 2010</a>), which may lend more support to studies which have applied this technique. Hydration levels will also influence sputum volume and has been identified as a mode of supporting airway clearance and sputum expectoration (<a href="./references#CD011699-bbs2-0140" title="WilkinsonM , SugumarK , MilanS , HartA , CrockettA , CrossinghamI . Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD001289.pub2] ">Wilkinson 2014</a>). In the absence of commentary about hydration levels in the studies included in this review, it is difficult to determine its contribution. </p> <p>That oscillatory PEP therapy has similar effects after a single session of treatment on measures of spirometry as other techniques (ranging from ACBT with GAD, AD, and ELTGOL in clinically stable participants (<a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>)) is not surprising. Single sessions of treatment offer little opportunity to make a substantial change in spirometry, even when experiencing an acute exacerbation. Similar effects were noted for minimal PEP therapy compared to ELTGOL or AD (<a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Even the use of four sessions of treatment or four weeks of treatment of either oscillatory PEP therapy or ACBT with GAD or GAD with chest clapping and compression suggested there was no greater advantage or detriment between techniques in measures of spirometry or peak expiratory flow rates (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>). The lack of advantage of oscillatory PEP therapy over GAD during an acute exacerbation upon spirometry measurements may be influenced by concurrent medical therapy administered as part of exacerbation management for all patients (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>). For this reason, the opportunity to identify a difference between techniques on measures of FEV<sub>1</sub> and FVC is limited. The same degree of reduction in FRC, RV, and TLC with oscillatory PEP therapy as ELTGOL indicates that both types of ACTs reduce pulmonary hyperinflation (<a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>), a feature of bronchiectasis (<a href="./references#CD011699-bbs2-0100" title="KoulourisN , RetsouS , KosmasE , DimakouK , MalagariK , MantzikopoulosG , et al. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. European Respiratory Journal2003;21(5):743‐8. ">Koulouris 2003</a>). The splinting effect of the oscillatory PEP therapy is believed to stabilise airways during expiration to avoid dynamic collage and favour pulmonary deflation (<a href="./references#CD011699-bbs2-0074" title="CalverleyP , KoulourisN . Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. European Respiratory Journal2005;25(1):186‐99. ">Calverley 2005</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>). This suggests that issues affecting patient compliance, such as preference for techniques, practical considerations, and cost are of greater importance and significance in selecting a technique. Similar findings were evident in a single session or up to three months of treatment with PEP therapy compared to other techniques in individuals with cystic fibrosis (<a href="./references#CD011699-bbs2-0113" title="McIlwaineM , ButtonBM , DwanK . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD003147.pub4] ">McIlwaine 2015</a>). Other measurements of lung function such as the lung clearance index, a measure of abnormal ventilation distribution, may provide more detailed information about the effects of specific ACTs on lung function (<a href="./references#CD011699-bbs2-0096" title="HorsleyA . Lung clearance index in the assessment of airways disease. Respiratory Medicine2009;103(6):793‐9. ">Horsley 2009</a>). With ventilation heterogeneity a clinical feature of bronchiectasis (<a href="./references#CD011699-bbs2-0093" title="GonemS , ScaddingA , SoaresM , SingpuriA , GustafssonP , OhriC , et al. Lung clearance index in adults with non‐cystic fibrosis bronchiectasis. Respiratory Research2014;15:59. ">Gonem 2014</a>), including this as an outcome in studies of PEP therapy may offer more insight into the physiological effects of this type of ACT. </p> <p>A key limitation of this review is the assumption that all ACTs are equivalent and effective compared to no treatment. While previous reviews have illustrated that, compared to no treatment, some types of ACTs are effective in improving sputum expectoration, lung function, HRQOL, and symptoms (<a href="./references#CD011699-bbs2-0104" title="LeeAL , BurgeAT , HollandAE . Airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD008351.pub3] ">Lee 2013</a>; <a href="./references#CD011699-bbs2-0105" title="LeeAL , WilliamsonHC , LorensiniS , SpencerLM . The effects of oscillating positive expiratory pressure therapy in adults with stable non‐cystic fibrosis bronchiectasis: a systematic review. Chronic Respiratory Disease2015;12(1):36‐46. ">Lee 2015</a>), this has not been proven for all types of ACTs. For this review, the comparator ACTs were variable. This may influence individual study findings and therefore the interpretation and findings of this current review need to be considered in view of the differing physiological rationale behind each comparator technique. </p> <p>A mix of cross‐over and randomised controlled trials have been included in this review. Cross‐over trials are more appropriate for comparing physiological outcomes between techniques, while controlled trials are more suited to comparing clinical outcomes. Despite this being a limitation of the current review, no meta‐analysis which combined cross‐over and controlled trials was undertaken. Being the first review to examine this question, future reviews may be better suited to separately examine the physiological and clinical impact of PEP therapy compared to other ACTs in this population. </p> <p>Six studies included participants whose diagnosis of bronchiectasis was according to HRCT (<a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a>; <a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a>; <a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a>). Given this is the gold standard for diagnosis, to minimise the likelihood of errors in diagnostic criteria, an update of this review could include studies in which a diagnosis of bronchiectasis was confirmed by HRCT only. In addition, while it is stated that studies which included participants with concurrent asthma or COPD were excluded, this relies on the original reporting of this information. The potential for some participants included in the current review having a concurrent respiratory condition cannot be excluded. The underlying causes of bronchiectasis or the extent of disease severity, including the number of lobes affected, were not specified in any study. Bronchiectasis severity can be determined by HRCT scan scoring (<a href="./references#CD011699-bbs2-0071" title="BhallaM , TurciosN , AponteV , JenkinsM , LeitmanB , McCauleyD , et al. Cystic fibrosis: scoring system with thin‐section CT. Radiology1991;179:783‐8. ">Bhalla 1991</a>) or a combination of clinical signs and symptoms (<a href="./references#CD011699-bbs2-0076" title="ChalmersJ , GoeminneP , AlibertiS , McDonnellMJ , LonniS , DavidsonJ , et al. The bronchiectasis severity index. An international derivation and validation study. American Journal of Respiratory and Critical Care Medicine2014;189(5):576–85. ">Chalmers 2014</a>). Knowledge of the severity of disease and the presence and degree of airway hyperresponsiveness does influence the selection of ACTs in cystic fibrosis (<a href="./references#CD011699-bbs2-0137" title="VolskoTA . Airway clearance therapy: finding the evidence. Respiratory Care2013;58(10):1669‐78. ">Volsko 2013</a>); this may be equally important in bronchiectasis. The range of intervention durations between studies (from single sessions to four weeks) makes it difficult to generalise the findings to broader clinical practice, which reflects the long‐term use of ACTs (<a href="./references#CD011699-bbs2-0073" title="ButlerS , HillLJ , HarrisonJ , ReedP , NikoraG , TakaiG , et al. Is there a difference in airway clearance practices between children with non cystic fibrosis bronchiectasis and cystic fibrosis?. New Zealand Journal of Physiotherapy2008;36:112‐7. ">Butler 2008</a>; <a href="./references#CD011699-bbs2-0103" title="LeeAL , ButtonBM , DenehyL . Current physiotherapy practice in Australia and New Zealand for patients with chronic obstructive pulmonary disease and bronchiectasis. New Zealand Journal of Physiotherapy2008;32:49‐58. ">Lee 2008</a>; <a href="./references#CD011699-bbs2-0118" title="O'NeillB , BradleyJM , McArdleN , MacMahonJ . The current physiotherapy management of patients with bronchiectasis: a UK survey. International Journal of Clinical Practice2002;56(1):34‐5. ">O'Neill 2002</a>), regardless of the chosen intervention. With a single study of PEP therapy during an acute exacerbation, further research is required to determine the impact of PEP therapy during this clinical state. </p> <p>The method of prescription of the common types of ACTs, including PEP therapy, aligned with current clinical guidelines for bronchiectasis, which have largely been extrapolated from the CF population and the findings are comparable to those described in the CF population (<a href="./references#CD011699-bbs2-0113" title="McIlwaineM , ButtonBM , DwanK . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD003147.pub4] ">McIlwaine 2015</a>). A large proportion of studies comparing PEP therapy to other ACTs have been undertaken in this group, due to the acceptance that airway clearance therapy is the cornerstone of CF management. The efficacy of PEP therapy is similar to GAD with manual techniques, ACBT, AD, and high frequency chest oscillation, with no differences in lung function or sputum volumes between techniques (<a href="./references#CD011699-bbs2-0113" title="McIlwaineM , ButtonBM , DwanK . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD003147.pub4] ">McIlwaine 2015</a>). A key factor is the consideration of patient preference. Adherence to treatment is increasingly recognised as important in bronchiectasis (<a href="./references#CD011699-bbs2-0110" title="McCulloughA , TunneyM , QuittnerA , ElbornJS , BradleyJ , HughesC . Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmonary Medicine2014;14:107. ">McCullough 2014</a>), with poor adherence influencing the rate of acute exacerbations. Adherence to ACT is associated with a higher burden of treatment and worsening respiratory symptoms (<a href="./references#CD011699-bbs2-0110" title="McCulloughA , TunneyM , QuittnerA , ElbornJS , BradleyJ , HughesC . Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmonary Medicine2014;14:107. ">McCullough 2014</a>). In people with bronchiectasis, adherence decision‐making involves patient evaluation of the advantages and disadvantages of adhering to treatment (<a href="./references#CD011699-bbs2-0111" title="McCullloughA , TunneyM , ElbornJ , BradleyJ , HughesC . 'All illness is personal to that individual': a qualitative study of patients' perspectives on treatment adherence in bronchiectasis. Health Expectations2015;18(6):2477‐88. ">McCullough 2014a</a>). Five studies included in the current review reported a preference for PEP therapy compared to ACBT with or without GAD or AD (<a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a>; <a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>; <a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a>); in view of similar effects on selected physiological outcomes, patient preference for a technique may be an important clinical consideration, particularly if this influences adherence rates in the longer term. In studies of individuals with cystic fibrosis (<a href="./references#CD011699-bbs2-0087" title="ElkinsMR , JonesA , Van derSchansC . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2006;Issue 2:CD003147. [DOI: 10.1002/14651858.CD003147.pub3] ">Elkins 2006</a>; <a href="./references#CD011699-bbs2-0113" title="McIlwaineM , ButtonBM , DwanK . Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD003147.pub4] ">McIlwaine 2015</a>) and in some studies in the current review (<a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a>; <a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a>), the independence, ease of use, and perception of effectiveness have been reported to be higher with PEP therapy. While no studies in the current review have considered participant adherence and its influence on the clinical outcomes of PEP therapy over other techniques, these may be important outcomes in future research. </p> </section> <section id="CD011699-sec-0083"> <h3 class="title" id="CD011699-sec-0083">Quality of the evidence</h3> <p>The quality of the nine studies included in this review is mixed, with small sample sizes and often unclear or high risk of bias for blinding of participants and of outcome assessors. Differing intervention duration and different comparative airway clearance techniques limited meta‐analysis. Little information on the primary outcomes of interest of quality of life, rate of acute exacerbations, and incidence of hospitalisations were available. While blinding of participants is difficult to achieve in cross‐over trials, which was the design of seven out of nine included studies, inclusion of assessor blinding and therapist blinding were not consistently undertaken. The absence of an adequate washout period within studies, particularly for those which applied treatment techniques on the same or consecutive days, may have influenced the short‐term outcomes. </p> <p>Review outcomes were rated as low quality (all outcomes) using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system. Imprecision was increased by the small number of included studies and participants, with one study contributing to each outcome. </p> </section> <section id="CD011699-sec-0084"> <h3 class="title" id="CD011699-sec-0084">Potential biases in the review process</h3> <p>This review was based on a published protocol (<a href="./references#CD011699-bbs2-0142" title="LeeAL , BurgeA , HollandAE . Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis. Cochrane Database of Systematic Reviews2015, Issue 5. [DOI: 10.1002/14651858.CD011699] ">Lee 2015a</a>). A broad search which incorporated handsearching of conference abstracts and trial registries was undertaken, with the inclusion of studies published only in the abstract form. Limited information was available from one paper (<a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a>), despite contacting the authors, with details only as reported in abstract form. Therefore, the ability to accurately assess the included data were limited. Two review authors independently extracted data and resolved disagreements via discussion. These two review authors independently rated the risk of bias. </p> </section> <section id="CD011699-sec-0085"> <h3 class="title" id="CD011699-sec-0085">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are similar to a previously published review of the effects of oscillatory PEP therapy compared to other ACTs in individuals with stable bronchiectasis (<a href="./references#CD011699-bbs2-0105" title="LeeAL , WilliamsonHC , LorensiniS , SpencerLM . The effects of oscillating positive expiratory pressure therapy in adults with stable non‐cystic fibrosis bronchiectasis: a systematic review. Chronic Respiratory Disease2015;12(1):36‐46. ">Lee 2015</a>). Oscillatory PEP therapy resulted in similar sputum expectoration as ACBT with GAD and, compared to other ACTs, had comparable impact on dynamic lung volumes, gas exchange, and breathlessness. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011699-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011699-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011699-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: Oscillatory PEP therapy vs ACBT with GAD (single session), Sputum weight (g)" data-id="CD011699-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: Oscillatory PEP therapy vs ACBT with GAD (single session), Sputum weight (g) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 1 CRQ Dyspnoea score." data-id="CD011699-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 1 CRQ Dyspnoea score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 2 CRQ Fatigue score." data-id="CD011699-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 2 CRQ Fatigue score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 3 CRQ Mastery score." data-id="CD011699-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 3 CRQ Mastery score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 4 CRQ Emotional function score." data-id="CD011699-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 4 CRQ Emotional function score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 5 CRQ Total score." data-id="CD011699-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks), Outcome 5 CRQ Total score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 1 Sputum weight (g)." data-id="CD011699-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 1 Sputum weight (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 2 Sputum volume (ml)." data-id="CD011699-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 2 Sputum volume (ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 3 Fatigue." data-id="CD011699-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 3 Fatigue. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 4 Discomfort." data-id="CD011699-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Oscillatory PEP therapy vs ACBT with GAD (single session), Outcome 4 Discomfort. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 1 Sputum weight (g)." data-id="CD011699-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 1 Sputum weight (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 2 Sputum volume (ml)." data-id="CD011699-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 2 Sputum volume (ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 3 Fatigue." data-id="CD011699-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 3 Fatigue.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 4 Discomfort." data-id="CD011699-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Oscillatory PEP therapy vs ACBT (single session), Outcome 4 Discomfort.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 1 Sputum weight (over 24 hours) Day 2 of admission." data-id="CD011699-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 1 Sputum weight (over 24 hours) Day 2 of admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 2 Sputum weight (over 24 hours) Day 4 of admission." data-id="CD011699-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 2 Sputum weight (over 24 hours) Day 4 of admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 3 Sputum weight (over 24 hours) Day of Discharge." data-id="CD011699-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 3 Sputum weight (over 24 hours) Day of Discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 4 FEV1 (Day 2 of admission)." data-id="CD011699-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 4 FEV1 (Day 2 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 5 FEV1 (Day 4 of admission)." data-id="CD011699-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 5 FEV1 (Day 4 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 6 FEV1 (Day of Discharge)." data-id="CD011699-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 6 FEV1 (Day of Discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 7 FVC (Day 2 of admission)." data-id="CD011699-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 7 FVC (Day 2 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 8 FVC (Day 4 of admission)." data-id="CD011699-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 8 FVC (Day 4 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 9 FVC (Day of Discharge)." data-id="CD011699-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 9 FVC (Day of Discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 10 PEFR (Day 2 of admission)." data-id="CD011699-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 10 PEFR (Day 2 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 11 PEFR (Day 4 of admission)." data-id="CD011699-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 11 PEFR (Day 4 of admission). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011699-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/urn:x-wiley:14651858:media:CD011699:CD011699-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_t/tCD011699-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 12 PEFR (Day of Discharge)." data-id="CD011699-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Oscillatory PEP vs GAD during acute exacerbation, Outcome 12 PEFR (Day of Discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/media/CDSR/CD011699/image_n/nCD011699-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011699-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Positive expiratory pressure (PEP) therapy compared with other airway clearance techniques for bronchiectasis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with bronchiectasis </p> <p><b>Settings:</b> hospital inpatient and outpatient department, home‐based therapy </p> <p><b>Intervention:</b> positive expiratory pressure (PEP) therapy </p> <p><b>Comparison:</b> other airway clearance techniques (ACTs) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Other airway clearance techniques (ACTs)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Positive expiratory pressure (PEP) therapy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cough‐related quality of life (QOL)</b> <br/> assessed with: Leicester cough questionnaire total score. Higher score indicates better QOL. 19 questions on 7‐point Likert scale<br/> Scale from: 3 to 21<br/> follow‐up: mean 1 week </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) was 0.5 points (95% CI 0.1 to 0.5) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) in the intervention group was 0.1 points lower </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised cross‐over trial of minimal PEP therapy vs Autogenic drainage. Duration of intervention of 1 week per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cough‐related quality of life (QOL)</b> <br/> assessed with: Leicester cough questionnaire total score. Higher score indicates better QOL. 19 questions on 7‐point Likert scale<br/> Scale from: 3 to 21<br/> follow‐up: mean 1 week </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) was 0.9 points (95% CI 0.5 to 2.1) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The median change in cough‐related quality of life (QOL) in the intervention group was 0.4 points lower </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomised cross‐over trial of minimal PEP therapy vs ELTGOL. Duration of intervention of 1 week per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life (HRQOL)</b> disease‐specific HRQOL </p> <p>assessed with: Chronic respiratory disease questionnaire total score</p> <p>Scale from: 0 to 28</p> <p>follow‐up: mean 4 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not provided</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mean difference (95% CI) between groups was ‐0.09 points per item (‐0.37 to 0.19) in favour of oscillatory PEP therapy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 participants (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised cross‐over trial of ACBT vs Oscillatory PEP therapy (Flutter). Duration of intervention of 4 weeks per ACT </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of acute exacerbations of bronchiectasis</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Duration of acute exacerbation of bronchiectasis ‐</b> not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>see comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of hospitalisation</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not provided</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>not provided</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies examined this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Small participant numbers </p> <p><sup>2</sup>Insufficient power for quality of life comparison </p> <p><sup>3</sup>Method of randomisation and allocation concealment unclear, lack of blinding of participants and personnel, no washout period applied </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011699-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Individual study outcomes for HRQOL</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study name</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Disease‐specific QOL</b> </p> <p>Dyspnoea domain: MD 0.01 (95% CI ‐0.48 to 0.50)</p> <p>Fatigue domain: MD ‐0.19 (95% CI ‐0.82 to 0.45)</p> <p>Emotional function domain: MD ‐0.06 (95% CI ‐0.63 to 0.52)</p> <p>Mastery domain: MD ‐0.10 (95% CI ‐0.65 to 0.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs ACBT (daily for 4 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Improved general health on SF‐36 (P = 0.048) with PEP therapy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs AD</p> <p>Minimal PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cough‐related quality of life (LCQ)</b> </p> <p>median 0.4 (95% CI 0.1 to 1.2) vs 0.5 (95% CI 0.1 to 0.5)</p> <p>median 0.4 (95% CI 0.5 to 2.1) vs 0.9 (95% CI 0.1 to 1.2)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; CI ‐ confidence interval; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; LCQ ‐ Leicester cough questionnaire; MD ‐ mean difference; PEP ‐ positive expiratory pressure; QOL ‐ quality of life; SF‐36 ‐ short form 36. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Individual study outcomes for HRQOL</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011699-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Individual study outcomes for sputum yield</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>dry weight (MD 0.28 g (SD 0.28) vs 0.16 g (0.06)), P &gt; 0.05</p> <p>wet weight (MD 7.2 g (SD 2.3) vs 6.3 g (0.7)), P &gt; 0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median difference 7.64 g, P = 0.77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2: MD 19.86 g (95% CI ‐7.95 to 47.67)</p> <p>Day 4: MD 22.46 g (95% CI ‐10.71 to 55.63)</p> <p>Day of discharge: MD 21.03 g (95% CI ‐11.29 to 53.35)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.54 g (95% CI ‐0.39 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MD 0.3 g (95% CI ‐1.42 to 0.82)</p> <p>MD ‐5.6 g (95% CI ‐10.1 to ‐1.0)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median 0.15 g (minimum to maximum 0.05 to 0.13 g) vs 0.38 g (0.06 to 2.63 g)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs AD</p> <p>Minimum PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>median difference 3.1 g (95% CI 1.5 to 4.8 g)</p> <p>median difference 3.6 g (95% CI 2.8 to 7.1 g)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 15.8 g (SD 5.7) vs 16.2 g (7.9)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique<sub>;</sub> AD ‐ autogenic drainage; CI ‐ confidence interval; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; g ‐ grams; GAD ‐ gravity assisted drainage; MD ‐ mean difference; PEP ‐ positive expiratory pressure; SD ‐ standard deviation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Individual study outcomes for sputum yield</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011699-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Individual study outcomes for lung function</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of </b> </p> <p><b> participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0002" title="DeOliveira AntunesLC , DeCrvalhoSM , BorgesFD , DeAssisVL , DeGodoyI . A study of the conventional chest physiotherapy versus Flutter VRP1 in the treatment of patients carrying bronchiectasis. Salusvita2001;20(1):23‐33. ">Antunes 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 1 PEFR: mean 405 L/min (SD 157) vs 439 L/min (175)</p> <p>Day 2 PEFR: 434 L/min(150) vs 417 L/min (134)</p> <p>Day 3 PEFR: 428 L/min(166) vs 419 L/min (157)</p> <p>Day 4 PEFR: 456 L/min(159) vs 462 L/min (185)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PEFR morning: median difference ‐2.5 L/min, P = 0.38)</p> <p>PEFR evening: median difference ‐2.72 L/min (95% CI ‐6.95 to 1.52), P = 0.30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0009" title="TsangSM , JonesAY . Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiotherapy Journal2003;21:29‐36. ">Tsang 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Day 2 FEV<sub>1</sub>: MD 0.12 L (95% ‐0.32 to 0.56) </p> <p>Day 4 FEV<sub>1</sub>: MD 0.15 L (95% CI ‐0.27 to 0.57) </p> <p>Day of discharge FEV<sub>1</sub>: (MD 0.12 L (95% CI ‐0.52 to 0.76) </p> <p>Day 2 FVC: MD ‐0.22 L (95% CI ‐0.81 to 0.37)</p> <p>Day 4 FVC: MD 0.2 L (95% CI ‐0.48 to 0.88)</p> <p>Day of discharge: FVC MD 0.12 L (95% CI ‐0.52 to 0.76)</p> <p>Day 2 PEFR: MD 22.2 L/min (95% CI ‐48.88 to 93.28)</p> <p>Day 4 PEFR: MD 22.6 L/min (95% CI ‐40.69 to 85.89)</p> <p>Day of discharge PEFR: MD 23.2 L/min (95% CI ‐39.56 to 85.96)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>: mean (SD) 65 (22) % predicted vs 65 (22) </p> <p>FVC: 81 (20) % predicted vs 81 (20)</p> <p>PEF: 68 (19) L/min vs 70 (18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference between techniques, MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0004" title="GuimaraesSF , MocoVJ , MenezesSL , DiasCM , SallesRE , LopesAJ . Effects of ELTGOL and Flutter VRP1 on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Revista Brasileira de Fisioterapia2012;16(2):108‐13. NCT01300403 . Physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in patients with bronchiectasis [Acute physiological effects of expiration with the glottis open in lateral posture (ELTGOL) and flutter valve in dynamic and static pulmonary volumes of patients with bronchiectasis]. clinicaltrials.gov/show/NCT01300403 (first received 18 February 2011). ">Guimaraes 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>: median 1.6 L (minimum to maximum ‐6.8 to 21.4) vs 2.2 L (‐20.2 to 20.9) </p> <p>FVC: median 2.44 L (minimum to maximum ‐3.9 to 8.1) vs 0.96 L (‐11.8 to 22.1)</p> <p>FEV<sub>1</sub>/FVC: median 0.7 L (minimum to maximum ‐11.3 to 19.6) vs 0.0 L (‐8.6 to 10.6) </p> <p>FEF<sub>25‐75</sub>: median 4.5 L (minimum to maximum ‐21.4 to 160.0) vs 6.0 (‐90.51 to 236) </p> <p>Change in IC: median 3.5 L (minimum to maximum 28.5 to 33.8) vs 2.7 (‐15.7 to 27.7)</p> <p>Change in TLC: median ‐18.3 L (minimum to maximum ‐42.4 to ‐6.4) vs 9.7 (‐40.0 to ‐1.9) </p> <p>Change in FRC: median ‐25.8 L (minimum to maximum ‐52.0 to ‐5.1) vs ‐14.5 L (‐55.7 to ‐3.6) </p> <p>Change in RV (median ‐29.6 L (minimum to maximum ‐54.7 to ‐8.9) vs ‐18.7 L (‐71.9 to ‐10.7) </p> <p>Change in RV/TLC ratio (median ‐5.2 L (minimum to maximum ‐22.8 to 27.6) vs ‐8.5 L (‐25.5 to 113.0) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0005" title="HerreroB , PolverinoE , SanMiguelM , AlcarazV , MartiD , VilaroJ , et al. Wet sputum as an objective outcome in a randomised crossover trial in NCF‐BE: reliability and responsiveness. European Respiratory Journal2014;44(Suppl 58):P4274. Herrero‐CortinaB , VilaroJ , MartiD , TorresA , San Miguel‐PagolaM , AlcarazV , et al. Short‐term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial. Physiotherapy2016;102(4):357‐64. [DOI: http://dx.doi.org/10/1016/j.physio.2015.07.005] NCT01854788 . Three airway clearance techniques in non cystic fibrosis bronchiectasis [A comparative study of three airway clearance techniques with different autonomy degrees in non cystic fibrosis bronchiectasis: randomized cross‐over trial]. clinicaltrials.gov/show/NCT01854788 (first received 8 August 2012). PolverinoE , HerreroB , VilaroJ , MartiD . Efficacy of airway clearance therapy with different autonomy degrees in nonCF BE: a randomised crossover trial. American Journal of Respiratory and Critical Care Medicine2012;185:A4876. ">Herrero‐Cortina 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal PEP therapy vs ELTGOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub>, FVC, FEF<sub>25‐75</sub> remain unchanged between techniques, MD NR, P &gt; 0.05 </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PEFR: mean 176.1 L/min (SD 72.6) vs 179.1 (72.6), P = 0.87</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; ELTGOL ‐ L'expiration Lente Totale Glotte Ouverte en Decubitus Lateral; FEF 25‐75 ‐ forced expiratory flow at 25 to 75% of forced vital capacity; FEV<sub>1</sub> ‐ forced expiratory volume in one second; FRC ‐ functional residual capacity; FVC ‐ forced vital capacity; GAD ‐ gravity assisted drainage; IC ‐ inspiratory capacity; L ‐ litres; L/min ‐ litres per minute; MD ‐ mean difference; NR ‐ not reported; PEFR ‐ peak expiratory flow rate; <sub>PEP ‐ positive expiratory pressure; RV ‐ residual volume; SD ‐ standard deviation;</sub> TLC ‐ total lung capacity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Individual study outcomes for lung function</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011699-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Individual study outcomes for symptoms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Number of participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Results</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0008" title="ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Flutter valve or conventional physiotherapy in productive non‐cystic bronchiectasis? A randomised crossover study. Thorax2000;55:A71. ThompsonCS , HarrisonS , AshleyJ , DayK , SmithDL . Randomised crossover study of the flutter device and the active cycle of breathing technique in non‐cystic fibrosis bronchiectasis. Thorax2002;57:446‐8. ">Thompson 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Borg dyspnoea scale morning: MD 0.13 (95% CI ‐0.078 to 0.34), P = 0.36</p> <p>Borg dyspnoea scale evening: median difference ‐0.04, P &gt; 0.99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0006" title="PattersonJE , BradleyJM , HewittO , BradburyI , ElbornJS . Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques vs Acapella. Respiration2005;72:239‐42. ">Patterson 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs ACBT with GAD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15‐count breathlessness score: MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0003" title="EatonT , YoungP , ZengI , KolbeJ . A randomised evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non‐cystic fibrosis bronchiectasis. Chronic Respiratory Disease2007;4:23‐30. ">Eaton 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT with GAD</p> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fatigue: MD ‐0.3 points (95% CI ‐0.35 to 0.95)</p> <p>Discomfort: MD ‐0.3 points (95% CI ‐0.82 to 0.22)</p> <p>Fatigue: MD 0.7 points (95% CI 0.15 to 1.25)</p> <p>Discomfort: MD 0.40 points (95% CI ‐0.12 to 0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0001" title="AltiayG , UzmezogluB , SutN , TunaH , NuriO . Evaluating flutter device and the active cycle of breathing technique in non‐cystic bronchiectasis. The prospective randomised study. European Respiratory Journal2012;40(Suppl 56):P2460. ">Altiay 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Flutter) vs ACBT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Borg and Medical Research Council scores: no difference between techniques, MD NR</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011699-bbs2-0007" title="SemwalS , MitraS , SinghSB . Autogenic drainage versus acapella for airway clearance in patients with bronchiectasis: randomised crossover trial. International Journal of Health Sciences and Research2015;5(9):323‐7. ">Semwal 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oscillatory PEP therapy (Acapella) vs AD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>mean 1.8 (SD 1.1) vs 1.8 (1.2), P = 1.00</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>ACBT ‐ active cycle of breathing technique; AD ‐ autogenic drainage; CI ‐ confidence interval; GAD ‐ gravity assisted drainage; MD ‐ mean difference; NR ‐ not reported; PEP ‐ positive expiratory pressure. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Individual study outcomes for symptoms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/full#CD011699-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011699-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 CRQ Dyspnoea score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 CRQ Fatigue score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 CRQ Mastery score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 CRQ Emotional function score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 CRQ Total score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oscillatory PEP therapy (Flutter) vs ACBT with GAD (4 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011699-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Oscillatory PEP therapy vs ACBT with GAD (single session)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Sputum weight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Sputum volume (ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Discomfort <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Oscillatory PEP therapy vs ACBT with GAD (single session)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011699-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oscillatory PEP therapy vs ACBT (single session)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Sputum weight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Sputum volume (ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Fatigue <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Discomfort <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oscillatory PEP therapy vs ACBT (single session)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011699-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oscillatory PEP vs GAD during acute exacerbation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Sputum weight (over 24 hours) Day 2 of admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Sputum weight (over 24 hours) Day 4 of admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sputum weight (over 24 hours) Day of Discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 FEV1 (Day 2 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 FEV1 (Day 4 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 FEV1 (Day of Discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 FVC (Day 2 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 FVC (Day 4 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 FVC (Day of Discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 PEFR (Day 2 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 PEFR (Day 4 of admission) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 PEFR (Day of Discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oscillatory PEP vs GAD during acute exacerbation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011699.pub2/references#CD011699-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011699.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011699-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011699-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD011699-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011699-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011699\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011699\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011699\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011699\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011699\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=i9CklieH&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011699.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011699.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011699.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011699.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011699.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716960281"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011699.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716960285"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011699.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dac3fb972f3f1',t:'MTc0MDcxNjk2MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 